Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.7940044514773018,1.8646149651817636,0.0,0.013237135952301152,0.013,8/35,2.63%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;TEC
prerank,platelet-derived growth factor binding (GO:0048407),-0.7490300832037202,-1.8576662757208042,0.006993006993006993,0.4071388284586254,0.259,6/11,16.72%,COL4A1;COL3A1;PDGFRA;COL1A2;COL6A1;COL1A1
prerank,phosphotyrosine residue binding (GO:0001784),0.7671796450507301,1.8174570630986597,0.0,0.03687487872426749,0.068,12/37,5.51%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.743163830286404,1.7789344183355855,0.0,0.0668160195687582,0.17,13/42,6.73%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1;YWHAB
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.8570462922001028,1.7612338592811425,0.0013736263736263737,0.08415036426820019,0.27,4/13,4.49%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.8641328280811529,1.7184206783196985,0.0029411764705882353,0.16867893242075185,0.527,3/10,2.57%,CYBB;NCF4;NCF2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.8470418917103266,1.7167098287877753,0.0025806451612903226,0.1441902309089947,0.536,6/15,8.40%,PTAFR;P2RX1;P2RX7;P2RX4;P2RY12;GPR34
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.734130464613668,1.7134687941612674,0.002280501710376283,0.13318179641805036,0.564,8/34,6.43%,BTK;MYO1G;ARHGAP9;DAPP1;IQGAP2;ARAP1;ADAP2;GAB2
prerank,kinase activator activity (GO:0019209),0.746083843369693,1.7127729687869637,0.0034482758620689655,0.1185432800014112,0.573,9/30,10.72%,NCKAP1L;TREM2;GPRC5B;FGF13;RGCC;WNK1;EPO;MALT1;DUSP19
prerank,chemokine receptor binding (GO:0042379),0.7340571923522362,1.7122464164753173,0.001148105625717566,0.10652742742566165,0.575,9/35,12.82%,PF4;CXCL5;CX3CR1;CXCL2;CCL8;CCL14;CCL13;CCL2;ITCH
prerank,CXCR chemokine receptor binding (GO:0045236),0.8523439643345654,1.7053877842194234,0.001430615164520744,0.10892271869322091,0.616,3/11,2.30%,PF4;CXCL5;CXCL2
prerank,protein phosphatase 1 binding (GO:0008157),0.7857046662611283,1.7018837041857848,0.0036900369003690036,0.10675664190102618,0.648,3/21,5.93%,LILRB1;PPP1R3E;PPP1R11
prerank,chemokine binding (GO:0019956),0.7538266331900839,1.696384553965907,0.0,0.10936395655829761,0.685,6/30,5.89%,CX3CR1;CCR2;ITGA4;ITGB3;CXCR4;HMGB1
prerank,SH2 domain binding (GO:0042169),0.7326280014618818,1.6962436499361182,0.001183431952662722,0.1010968075477945,0.685,6/31,3.58%,SLAMF1;LILRB1;BLNK;SH3PXD2B;NUP62;LAT2
prerank,MHC protein binding (GO:0042287),0.7577334421580958,1.6941037081229409,0.0024752475247524753,0.09765764585218095,0.702,3/20,1.34%,TUBB;LILRB1;CD74
prerank,lipase activity (GO:0016298),0.6935100351605535,1.6633547237792035,0.0033076074972436605,0.15676551006368078,0.87,9/43,6.37%,PLBD1;LPL;DAGLB;ABHD12;DDHD1;CEL;LIPA;SMPD3;LIPC
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.7998153316456911,1.6630981864367393,0.007072135785007072,0.1472040431124204,0.87,5/14,7.90%,CYBB;NCF4;NCF2;MICAL1;KMO
prerank,chemokine activity (GO:0008009),0.7215605367249677,1.660700629735461,0.0034965034965034965,0.1436618578352684,0.884,7/31,11.36%,PF4;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2
prerank,anion:anion antiporter activity (GO:0015301),-0.5782663714204469,-1.6585119129735928,0.012396694214876033,1.0,0.859,8/17,25.36%,SLC26A2;SLC26A7;SLC25A4;SLC25A11;SLC19A1;SLC4A2;SLC25A5;SLC26A6
prerank,C-C chemokine receptor activity (GO:0016493),0.7649749400356233,1.645588149544535,0.0024271844660194173,0.17176759747628875,0.936,3/21,4.42%,CX3CR1;CCR2;CXCR4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.8050310040155951,1.6436971515611327,0.006501950585175552,0.16755427350149618,0.941,4/15,9.95%,CX3CR1;CCR2;GPR17;CMKLR1
prerank,amyloid-beta binding (GO:0001540),0.6461361165843078,1.6259728747542554,0.0,0.20602656600045866,0.973,27/79,15.68%,TREM2;LILRB1;LILRB3;GSAP;CALCR;FCGR2B;ITGB2;CD74;CLSTN1;TLR2;ITGA2;MSR1;APOE;LDLRAP1;APBA1;CACNA1A;C1QA;BCHE;ITGAM;IAPP;ITM2B;SORL1;CACNA1B;LRP1;PFDN1;CD36;GRIA1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7391896203374988,1.625807382232685,0.007556675062972292,0.19671104413470655,0.973,11/22,14.74%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;ATP2C1;ATP6V0A1;ATP2A3;ATP6V0B
prerank,C-C chemokine binding (GO:0019957),0.745960264748065,1.6246675455113626,0.007134363852556481,0.1908640284550955,0.975,3/22,4.42%,CX3CR1;CCR2;CXCR4
prerank,phospholipase binding (GO:0043274),0.8027748066311169,1.6237768883320658,0.009776536312849162,0.1849910303893018,0.975,3/13,0.97%,BTK;BLNK;SYK
prerank,lipoprotein particle binding (GO:0071813),0.7477241832058588,1.6096862821281255,0.01371571072319202,0.21482768555922077,0.988,9/20,12.90%,TREM2;PCSK9;LPL;MSR1;STAB2;LIPC;STAB1;THBS1;SORL1
prerank,cytokine receptor activity (GO:0004896),0.6403202321356305,1.6085255268340384,0.002053388090349076,0.20907110726948788,0.988,15/83,6.04%,IL10RA;CX3CR1;FLT3;CCR2;CSF3R;CD74;CSF2RB;IL10RB;IL21R;IL12RB2;IL6R;IFNAR1;CD44;IFNGR2;GPR17
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.7203644832507572,1.6079302200300765,0.008484848484848486,0.20288456449969267,0.988,5/25,6.43%,MYO1G;DAPP1;PLEK;ADAP2;GAB2
prerank,phospholipase activity (GO:0004620),0.6468425440318947,1.6073628448028867,0.002079002079002079,0.19677107649730205,0.988,11/67,6.37%,PLBD1;PLD4;PLCB2;PNPLA7;LPL;ABHD12;DDHD1;SMPD3;ASPG;PLD3;LIPC
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.7496540753363077,1.602633322000612,0.017310252996005325,0.19464458530846768,0.99,7/16,10.59%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.7496540753363077,1.602633322000612,0.017310252996005325,0.19464458530846768,0.99,7/16,10.59%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,low-density lipoprotein particle binding (GO:0030169),0.762907504941726,1.602165220924997,0.011597938144329897,0.18922801013718124,0.99,9/16,15.32%,TREM2;PCSK9;MSR1;STAB2;LIPC;STAB1;THBS1;SORL1;CD36
prerank,chemokine receptor activity (GO:0004950),0.7299199245174717,1.5976061862952096,0.00966183574879227,0.19559850889886474,0.994,5/24,9.95%,CX3CR1;CCR2;CXCR4;GPR17;CMKLR1
prerank,MHC class I protein binding (GO:0042288),0.775329752170402,1.5960038018119855,0.02109704641350211,0.19329764151775478,0.996,5/13,12.96%,TUBB;LILRB1;DERL1;TAP1;ATP5F1A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.7330111817077097,1.5948372897918839,0.01589242053789731,0.19033396998081506,0.997,3/21,5.60%,P2RX1;P2RX7;P2RX4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.8058497911552276,1.586770094165846,0.022253129346314324,0.20484189795094598,0.998,3/11,6.82%,AQP1;HCN4;CNGB1
prerank,kinesin binding (GO:0019894),0.6906711967424879,1.586446050763082,0.01437125748502994,0.19977269462707556,0.998,9/27,9.40%,PLEKHM2;SPTBN5;NEFH;CLSTN1;KLC2;NEK6;SNCA;ACTB;ATCAY
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.784326383573969,1.5742865262951895,0.019099590723055934,0.2273950854663162,0.999,3/12,2.70%,PIK3CG;PIK3CD;PIK3CB
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.8073308094591212,1.571788836313728,0.021037868162692847,0.2277656230557146,0.999,3/10,2.70%,PIK3CG;PIK3CD;PIK3CB
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.6208480719623332,1.5684992528703487,0.0010214504596527069,0.23080389679237875,0.999,19/100,8.74%,BTK;DENND1C;MYO1G;ARHGAP9;DAPP1;NCF4;PLEKHN1;SH3PXD2B;IQGAP2;ZFYVE26;ARAP1;SNX24;ZFYVE28;ADAP2;GAB2;DENND1A;SNX27;TECPR1;DENND1B
prerank,triglyceride lipase activity (GO:0004806),0.7167588229718288,1.5684466149522973,0.02918781725888325,0.22507979886660054,0.999,6/20,17.15%,LPL;DAGLB;CEL;LIPC;LIPE;PNPLA3
prerank,glutamate receptor activity (GO:0008066),-0.511664436985479,-1.5662874711280463,0.06422018348623854,1.0,0.983,5/19,10.17%,GRM7;GRIK4;GRIA2;GRM5;GRM1
prerank,protein tyrosine kinase binding (GO:1990782),0.6216031679058402,1.5635404869506015,0.002068252326783868,0.23332815890207978,1.0,15/71,8.16%,TREM2;BLNK;ITGAX;CASS4;SIRPA;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;TP53;NEDD9;DOCK4;FLT3LG
prerank,dynactin binding (GO:0034452),0.7819626095891483,1.5512571057260958,0.033602150537634407,0.26365884206038165,1.0,3/12,2.03%,HOOK3;SPTBN5;SNX5
prerank,carboxylic ester hydrolase activity (GO:0052689),0.6119655824394579,1.5462826217211962,0.0030706243602865915,0.27187906614955953,1.0,25/85,17.15%,PNPLA7;LPL;DAGLB;ABHD12;ESD;CEL;LIPA;ASPG;LIPC;PON3;PLA2G7;BCHE;PAFAH1B2;ABHD4;PGAP1;PRDX6;ABHD3;LIPE;GDE1;ABHD16A;GDPD3;TARS2;PLAAT3;PGLS;PNPLA3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.6110661410475996,1.5410313613970819,0.003080082135523614,0.28035462357448454,1.0,26/78,16.18%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;ESPL1;CAPN15;PYCARD;CASP1;USP35;CFLAR;MALT1;CTSZ;USP7;USP48;CASP7;USP18;CASP8;USP9X;CAPN2;CAPN3;USP8;USP29;PDIA3;USP16
prerank,GTPase activator activity (GO:0005096),0.5990163937234118,1.5409130914320046,0.0,0.2743052604401367,1.0,78/313,11.99%,ARHGAP45;ARHGAP30;NCKAP1L;FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;RIN3;THY1;RINL;ARHGAP24;GNAQ;VAV2;ELMO1;ARHGEF18;ARAP1;RASA4;FNIP1;ASAP1;RIC8A;VAV3;RASGRP2;RAB3GAP2;ARFGEF1;TBC1D16;TBC1D22A;TAGAP;FGD6;RGL2;USP6NL;DENND2C;RP2;DOCK11;MYO9B;DOCK10;GAPVD1;DOCK4;TBC1D10A;DENND1A;FLCN;RASGRP3;ITSN1;DENND1B;SIPA1;ARHGAP10;DENND4B;ARHGAP1;ACAP2;ARFGEF2;RAP1GAP2;DENND4C;EIF2B2;ARHGEF17;TBC1D2;NRP1;RAPGEF1;TBC1D17;TBC1D2B;ADAP1;DENND4A;CYTH1;ARHGAP27
prerank,diacylglycerol kinase activity (GO:0004143),0.7730287648021945,1.5383885404757642,0.031791907514450865,0.2767611980376361,1.0,7/11,12.92%,DGKZ;DGKK;DGKE;DGKD;DGKG;AGK;DGKI
prerank,receptor tyrosine kinase binding (GO:0030971),0.6234312848456621,1.5281258855186324,0.01694915254237288,0.3028919804240835,1.0,17/56,13.86%,BLNK;ITGAX;STAP1;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;GAB2;TP53;DOCK4;FLT3LG;SH2B3;NRG1;GAS6;TRADD
prerank,mannose binding (GO:0005537),0.7818362690535086,1.5275259911739472,0.026499302649930265,0.2984189585356159,1.0,2/12,1.80%,CLEC4D;LMAN1L
prerank,cysteine-type peptidase activity (GO:0008234),0.6072056614082373,1.5252710136691991,0.008247422680412371,0.29943110656388366,1.0,29/73,16.70%,CTSS;CTSB;LGMN;CTSC;OTULINL;CTSK;CTSL;ESPL1;OTULIN;CASP1;USP35;MALT1;CTSZ;TINAGL1;USP7;USP48;CASP7;GGH;USP18;CASP8;USP9X;CAPN2;CAPN3;USP8;USP29;PDIA3;USP21;USP16;ATG4A
prerank,GTPase regulator activity (GO:0030695),0.5904292103424951,1.5202164667483455,0.0,0.3083519424457324,1.0,48/212,11.99%,ARHGAP45;ARHGAP30;NCKAP1L;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SIRPA;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;THY1;ARHGAP24;GNAQ;ARAP1;RASA4;ASAP1;RIC8A;VAV3;RAB3GAP2;ARFGEF1;TBC1D16;TBC1D22A;TAGAP;USP6NL;RP2;MYO9B;TBC1D10A;FLCN;RASGRP3;SIPA1;ARHGAP10;ARHGAP1;ACAP2;RAP1GAP2;TBC1D2;NRP1;TBC1D17;TBC1D2B;ADAP1;ARHGAP27
prerank,phosphatidylinositol kinase activity (GO:0052742),0.737219069007367,1.518125687099487,0.0267022696929239,0.30910603468044945,1.0,4/15,4.92%,PIK3CG;PIK3CD;PIK3CB;PI4K2A
prerank,sterol transfer activity (GO:0120015),0.7047270403165852,1.5053664692024138,0.059045226130653265,0.3455374508109088,1.0,7/17,18.99%,ABCA1;NPC2;ABCG1;OSBP;STARD4;STARD5;GRAMD1C
prerank,tau protein binding (GO:0048156),0.6337368506630411,1.5039084814391066,0.027442371020856202,0.34318365929084055,1.0,21/40,21.50%,BAG2;LGMN;PPP2CB;S100B;SNCA;APOE;ACTB;HDAC6;PPP2CA;FYN;STUB1;GSK3A;HSP90AA1;BIN1;TAOK1;PICALM;ROCK2;GSK3B;MARK1;BRSK1;PIN1
prerank,protein tyrosine kinase activity (GO:0004713),0.5894851276209176,1.5022552479032345,0.004048582995951417,0.3421139570852819,1.0,12/108,4.35%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TYK2;TEC;TTN
prerank,aspartic-type peptidase activity (GO:0070001),0.7741103483668628,1.5020563314225002,0.045845272206303724,0.3363388154864455,1.0,4/10,9.96%,NAPSA;CTSD;DDI2;CTSE
prerank,CCR chemokine receptor binding (GO:0048020),0.6604349779443277,1.5019058726005718,0.03150525087514586,0.3307221057797007,1.0,5/28,11.36%,CCR2;CCL8;CCL14;CCL13;CCL2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.5903204667250114,1.5004012614579003,0.0,0.3296789752610106,1.0,38/147,11.90%,FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;PREX1;ABR;RIN2;RIN3;RINL;VAV2;ELMO1;ARHGEF18;FNIP1;RIC8A;VAV3;RASGRP2;RAB3GAP2;ARFGEF1;FGD6;RGL2;DENND2C;DOCK11;DOCK10;GAPVD1;DOCK4;DENND1A;ITSN1;DENND1B;DENND4B;ARFGEF2;DENND4C;EIF2B2;ARHGEF17;RAPGEF1;DENND4A;CYTH1
prerank,ankyrin binding (GO:0030506),0.6874426242925574,1.4987931127990444,0.0484472049689441,0.3288715004891261,1.0,3/19,3.21%,PTPRC;KCNJ11;SLC8A1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.6741989264467718,1.4970893993691274,0.03869407496977025,0.32856462453033214,1.0,5/24,6.42%,PTK2B;MAPKAPK3;CAMK1D;MYLK3;MKNK1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.4222734799445954,-1.490593225532123,0.026490066225165563,1.0,0.996,11/32,21.53%,KCNQ3;KCNQ5;KCNA1;KCNS3;KCNA2;KCNB2;KCNC1;KCNC3;KCNH1;KCNQ2;KCNQ4
prerank,ephrin receptor binding (GO:0046875),0.6810891118031913,1.4905253220334205,0.05024509803921569,0.34382899740511047,1.0,6/21,6.46%,LYN;PIK3CG;CBL;GRB2;PTPN1;EFNA2
prerank,WW domain binding (GO:0050699),0.6636154214169918,1.4896269207520372,0.051807228915662654,0.34087200926693595,1.0,6/26,11.59%,NFE2;TCEAL3;TCEAL6;KIF20B;LITAF;TCEAL8
prerank,lipase activator activity (GO:0060229),0.7488642238537032,1.4844683843868605,0.0703012912482066,0.35165211165088556,1.0,5/10,17.75%,BTK;CCL8;FYN;SRC;PDPK1
prerank,lysophospholipase activity (GO:0004622),0.668463469036835,1.4814463293933418,0.046341463414634146,0.3553743998807301,1.0,7/20,15.61%,PNPLA7;ABHD12;ASPG;ABHD4;GDE1;ABHD16A;GDPD3
prerank,steroid hydroxylase activity (GO:0008395),0.7004748868551961,1.4796634381231892,0.059219380888290714,0.3556917483781602,1.0,1/16,0.45%,CYP1A1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5960613500303513,1.474274775529805,0.013388259526261586,0.36730097549789203,1.0,11/73,12.03%,CALCR;GP1BA;CX3CR1;CYSLTR2;EDNRB;GALR1;CCKBR;SORCS3;CYSLTR1;GPR37;LTB4R2
prerank,cholesterol transfer activity (GO:0120020),0.6971199843187018,1.4694175749446625,0.08080808080808081,0.3774474765827585,1.0,6/16,18.99%,ABCA1;NPC2;ABCG1;STARD4;STARD5;GRAMD1C
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.7345065623325235,1.4682586689879666,0.06302521008403361,0.3753960070282461,1.0,5/12,13.86%,BLNK;STAP1;GAB2;SH2B3;TRADD
prerank,ligand-gated channel activity (GO:0022834),-0.41401414276624715,-1.4626841424034673,0.057692307692307696,1.0,0.998,7/29,13.14%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7028214824963775,1.4617471939716746,0.060240963855421686,0.3857957711476342,1.0,6/16,15.35%,PTPRC;PTPRE;PTPRO;PTPRU;PTPRT;PTPRA
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7028214824963775,1.4617471939716746,0.060240963855421686,0.3857957711476342,1.0,6/16,15.35%,PTPRC;PTPRE;PTPRO;PTPRU;PTPRT;PTPRA
prerank,3'-5' DNA helicase activity (GO:0043138),0.6944449886054886,1.4612191120864977,0.0611183355006502,0.38178037760565464,1.0,5/16,10.07%,MCM5;DHX9;NAV2;MCM2;MCM6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7145963075749688,1.4609098019831666,0.06473829201101929,0.3772988964853348,1.0,2/14,3.02%,AKR1A1;DHRS3
prerank,water transmembrane transporter activity (GO:0005372),0.7446330089662803,1.4597289648282166,0.06647807637906648,0.3756603300588161,1.0,2/11,8.26%,AQP1;AQP11
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5681301027930457,-1.459132461345322,0.07608695652173914,1.0,0.998,8/12,32.50%,CRYZL1;DHRS4;AIFM2;NQO2;CBR4;NDUFS7;CRYZ;NQO1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5992590432590958,-1.4572331066225204,0.09259259259259259,1.0,0.999,6/10,22.60%,GNAS;IGSF11;SHANK3;SHANK1;SHANK2;SHISA7
prerank,ligand-gated ion channel activity (GO:0015276),-0.4115152916583792,-1.4560769039116284,0.060810810810810814,1.0,0.999,7/30,13.14%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,chemoattractant activity (GO:0042056),0.6422435404067107,1.453298878093699,0.05680473372781065,0.39103392584491214,1.0,5/26,8.75%,GPNMB;LGALS3;HMGB1;VEGFB;NTF3
prerank,thyroid hormone receptor binding (GO:0046966),0.6322283818688559,1.4482066436205323,0.058402860548271755,0.4020877186920127,1.0,6/28,3.52%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1
prerank,phospholipase activator activity (GO:0016004),0.7437776558995683,1.4466929726567395,0.08320950965824665,0.40113888341939635,1.0,5/10,17.75%,BTK;CCL8;FYN;SRC;PDPK1
prerank,P-type ion transporter activity (GO:0015662),0.7268501033297023,1.446552664922686,0.05694444444444444,0.3961433552658658,1.0,6/12,13.62%,ATP7A;ATP6V1E1;ATP2C1;ATP2B1;ATP2B3;ATP2A3
prerank,Toll-like receptor binding (GO:0035325),0.7454555352139234,1.4416679119953466,0.07757404795486601,0.4064198846708402,1.0,3/11,2.12%,TLR1;TLR2;UNC93B1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5768712677708435,1.439329474087441,0.031088082901554404,0.4088654135470978,1.0,15/71,11.53%,PTPRC;PTPN7;UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18;PALD1;PTPRE;PTP4A2;MTMR3;PTP4A1;TIMM50;PTPRO;PTPRU
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.6373112462708876,1.4336629404645311,0.052132701421800945,0.4226428407627582,1.0,3/29,1.29%,MGAM;HPSE;GUSB
prerank,acetylcholine receptor activity (GO:0015464),-0.45374763594901996,-1.426001494075863,0.07655502392344497,1.0,1.0,5/22,21.71%,CHRM2;CHRFAM7A;CHRNA7;CHRM3;CHRNB1
prerank,DNA replication origin binding (GO:0003688),0.6515197389852315,1.4222420743588622,0.06459627329192547,0.4565256001488021,1.0,9/23,13.79%,MCM5;ORC3;DHX9;MCM2;MCM6;ORC4;MCM9;KAT7;CDC6
prerank,metal ion:proton antiporter activity (GO:0051139),0.6979282557149152,1.420750753854046,0.09164420485175202,0.4555938541868793,1.0,4/13,7.13%,SLC11A1;SLC9A4;SLC9A9;SLC9A1
prerank,cytokine activity (GO:0005125),0.5529310137017843,1.4181953982719797,0.013131313131313131,0.458653920491902,1.0,18/131,11.36%,PF4;CXCL5;TGFB1;IL1A;CXCL2;SLURP1;OSM;CCL8;TNF;TIMP1;IL18;NDP;HMGB1;EPO;CCL14;INHBA;CCL13;CCL2
prerank,actin monomer binding (GO:0003785),0.6459549212481238,1.4127314925648873,0.07897934386391252,0.4722359781589667,1.0,9/22,12.84%,CORO1A;MYL3;MRTFA;MTSS1;TMSB4X;PFN2;PFN1;TWF2;TMSB10
prerank,endoribonuclease activity (GO:0004521),0.5974085944462902,1.4114356775830887,0.07033997655334115,0.4710802779995779,1.0,8/32,11.76%,SLFN14;ERN1;NOB1;SND1;ENDOV;ZC3H12D;RNASEL;AGO3
prerank,MAP kinase kinase activity (GO:0004708),0.6818059932093807,1.4066731345341092,0.10299869621903521,0.4822549768200599,1.0,6/15,14.11%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2
prerank,protein kinase activator activity (GO:0030295),0.5716106503521954,1.4020069013712118,0.05005213764337852,0.49292202139018565,1.0,23/60,18.86%,NCKAP1L;GPRC5B;FGF13;RGCC;WNK1;EPO;ABI1;DBF4;MAP2K2;DUSP19;PARP16;NRG1;GAS6;STK3;STRADA;INCENP;ERCC6;ALS2;IRGM;STK4;IQGAP1;TAOK1;RPTOR
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6713371962889879,1.384834045240935,0.12027972027972028,0.5488683871650585,1.0,4/13,15.49%,EHHADH;SREBF2;ECI1;ECH1
prerank,carbohydrate kinase activity (GO:0019200),0.6950625746660176,1.3796242244603587,0.12175102599179206,0.5622522401414616,1.0,5/11,15.08%,HK3;NAGK;POMK;HK2;XYLB
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5963193111824694,1.3728132777365394,0.10593713620488941,0.5819719714743441,1.0,7/29,10.17%,MAPKAPK3;NFATC1;PTPRJ;MAPK14;GCH1;DUSP10;TPR
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7028329025046902,1.3724875457120602,0.13218390804597702,0.5766865577036625,1.0,2/10,3.27%,PRKAR2B;PKIB
prerank,phospholipase inhibitor activity (GO:0004859),0.6881051885122037,1.3702161420358638,0.1352154531946508,0.5791141922497212,1.0,4/10,9.73%,ANGPTL3;SNCA;ANXA1;ANXA4
prerank,bHLH transcription factor binding (GO:0043425),0.6426768456016996,1.369865468202678,0.1251564455569462,0.5742361010014347,1.0,5/19,8.62%,ASCL1;BHLHE41;USF1;LMO2;SMAD3
prerank,SH3 domain binding (GO:0017124),0.5496722967263766,1.3698345650298749,0.058572949946751864,0.5680663452076815,1.0,14/62,12.60%,SH3BP2;CD3E;CBL;GRB2;ELMO1;WIPF1;AKAP5;DNM2;WASF2;MICAL1;ABI1;ZNF106;ARHGAP27;SYNJ1
prerank,protein kinase regulator activity (GO:0019887),0.5429915593443244,1.3673150990324348,0.042726347914547304,0.5711081989128762,1.0,17/95,10.72%,NCKAP1L;GMFG;PRKAR2B;TAOK3;GPRC5B;FGF13;CCND3;SNCA;RGCC;DNAJC3;CCND2;YWHAB;WNK1;EPO;QARS1;CCNL1;DUSP19
prerank,retinoic acid binding (GO:0001972),-0.5396572197289072,-1.3672866804566899,0.12359550561797752,1.0,1.0,1/12,0.38%,NR2F2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6904183384877987,1.3664176478026966,0.13617021276595745,0.5681809259404522,1.0,6/12,9.83%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5805344062480057,1.365424773206888,0.09492273730684327,0.5656636254504029,1.0,12/38,14.11%,BLNK;CD3E;STAP1;LAT;NUP62;NCK2;LDLRAP1;GAB2;MMS19;SH2B3;TRADD;LRRK2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6786293562901361,1.364454079060859,0.13797814207650272,0.5632972593154463,1.0,3/13,3.71%,ITGB3;PTPRJ;ERN1
prerank,cholesterol binding (GO:0015485),0.5635782765640509,1.35708673762016,0.08494623655913978,0.585153540760376,1.0,18/47,21.38%,TSPO;ABCA1;NPC2;ABCG1;NPC1;SOAT2;ERLIN2;ERLIN1;OSBPL10;VDAC2;STARD4;VDAC1;OSBPL8;STARD5;GRAMD1C;OSBPL7;STARD3;SCARB2
prerank,ligand-gated cation channel activity (GO:0099094),0.5454684284861308,1.3567046373108558,0.05399792315680166,0.5806297950039618,1.0,7/75,6.13%,PTK2B;KCNJ11;P2RX1;P2RX7;KCNK6;P2RX4;CCDC51
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.69824873475618,1.355841137561336,0.12698412698412698,0.5780502550599042,1.0,3/10,12.70%,APOBEC1;CDA;LACC1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.48951451875249363,-1.3476245176449073,0.15416666666666667,1.0,1.0,7/14,14.34%,RECK;COL4A3;SPOCK2;TIMP2;TIMP3;NGF;BST2
prerank,G protein-coupled receptor activity (GO:0004930),0.5233529769697345,1.3458383301776884,0.003,0.6094093739526186,1.0,26/239,11.07%,GPR141;CNR2;LPAR6;CALCR;PTAFR;CX3CR1;ADGRE1;P2RY6;CYSLTR2;ADGRG5;ADGRE5;FFAR2;MRGPRF;CXCR4;LGR6;S1PR4;ADGRG3;GALR1;GPR17;P2RY12;GPR34;GPR183;XPR1;CMKLR1;CYSLTR1;GPR37
prerank,hormone activity (GO:0005179),0.5507063936533356,1.34477248051417,0.09498399146211313,0.6074853084983921,1.0,6/54,10.93%,TSHB;METRNL;PPY;INHBA;VGF;CHGB
prerank,C2H2 zinc finger domain binding (GO:0070742),0.673719327146523,1.3433777173410884,0.181058495821727,0.6067484129957086,1.0,1/11,1.20%,GATA1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.5345591715759687,1.3417525224018192,0.07523510971786834,0.6069713358544414,1.0,19/74,15.08%,HK3;PIK3CG;DGKZ;PIK3CD;PIK3CB;CHKB;DGKK;DGKE;NADK;DGKD;DGKG;AGK;FAM20C;PAPSS1;POMK;DGKI;SHPK;HK2;XYLB
prerank,transforming growth factor beta receptor binding (GO:0005160),0.631268649791572,1.3409547745043835,0.14267990074441686,0.6041079737352383,1.0,6/18,13.07%,TGFB1;TGFBR1;TGFBR2;TGFBRAP1;SMAD3;BAMBI
prerank,single-stranded DNA helicase activity (GO:0017116),0.6169689185350994,1.3399822234418814,0.11944091486658195,0.6019655110716868,1.0,5/19,12.45%,MCM5;DHX9;MCM2;MCM6;DNA2
prerank,E-box binding (GO:0070888),0.5769237594887153,1.3386048635727628,0.1087202718006795,0.6011479382543018,1.0,7/34,8.57%,ASCL1;SREBF2;MITF;BHLHE41;TAL1;SNAI1;CIART
prerank,copper ion binding (GO:0005507),0.5532328023362795,1.330099617021105,0.10990206746463548,0.6257683708932966,1.0,7/42,6.80%,IL1A;SNCA;ATP7A;ATOX1;RNF7;P2RX4;TP53
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.42304992035165656,-1.327815008007228,0.12315270935960591,1.0,1.0,4/22,14.54%,CHRM2;HTR2C;HTR7;CHRM3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.42304992035165656,-1.327815008007228,0.12315270935960591,1.0,1.0,4/22,14.54%,CHRM2;HTR2C;HTR7;CHRM3
prerank,serotonin receptor activity (GO:0099589),-0.42304992035165656,-1.327815008007228,0.12315270935960591,1.0,1.0,4/22,14.54%,CHRM2;HTR2C;HTR7;CHRM3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.539230625186654,-1.3268534404699852,0.1554054054054054,1.0,1.0,6/10,14.44%,ATF2;USP22;HAT1;BRCA2;NAA60;MSL3
prerank,serine-type endopeptidase activity (GO:0004252),0.529303187077674,1.3241909744064573,0.07392197125256673,0.6418872823325186,1.0,5/80,4.79%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,glutamate receptor binding (GO:0035254),-0.45427647681486194,-1.323045786674852,0.14042553191489363,1.0,1.0,9/17,15.34%,GNAS;SYNDIG1;IGSF11;HOMER3;SHANK3;SHANK1;SHANK2;CAMK2A;HOMER2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.5099073188828385,1.3224122458259557,0.016,0.6424781857425538,1.0,46/188,14.67%,RUNX1;AHRR;CIITA;GATA1;NFE2L2;POU2F2;BASP1;DHX9;TNF;SNCA;ATF3;FOXO3;CEBPA;DDIT3;SPI1;MAFK;HDAC5;HMGB1;XRCC5;FLI1;CREB3L1;TFEB;TP53;TBL1XR1;NKX2-1;TAL1;YY1;CEBPB;MEF2C;SMAD3;HSF1;ARID4A;HNRNPL;HDAC4;TBL1X;RNF10;CREB3L2;RBBP5;ATF6B;NFKB1;IRF1;FOXK1;SOX6;SOX2;BRD7;SOX4
prerank,protein phosphatase binding (GO:0019903),0.5231205434021055,1.3203030798100903,0.045408678102926335,0.6445625654488044,1.0,19/117,9.45%,CD22;LILRB1;LGALS3;SIRPA;PPP1R3E;KCNN4;MAPK14;PPP6R1;TRAF2;AKAP5;TRAF3;PPP1R11;CTNNB1;TP53;MAP3K5;SLC9A1;MTMR3;ENSA;STRN
prerank,GABA receptor binding (GO:0050811),0.667687212869045,1.3156951765101463,0.17832647462277093,0.6548804692077638,1.0,3/11,9.41%,PLCL2;AKAP5;ARFGEF2
prerank,sodium channel regulator activity (GO:0017080),0.5556330835621699,1.3122468693039633,0.11851015801354402,0.6619158919719875,1.0,12/37,20.42%,PCSK9;SCN4B;FGF13;PKP2;PRSS8;NEDD4L;FXYD5;SGK3;YWHAH;PTPN3;FXYD6;FXYD1
prerank,phosphatase inhibitor activity (GO:0019212),0.5991716416274381,1.3046483508001603,0.1728395061728395,0.685051071230594,1.0,5/20,11.32%,LGALS3;MGAT5;SAG;ENSA;BOD1L1
prerank,receptor antagonist activity (GO:0048019),0.6136789469100448,1.3031397917401872,0.17197452229299362,0.6848724945246037,1.0,3/17,12.95%,DKK2;IL18BP;PXDN
prerank,cation:chloride symporter activity (GO:0015377),-0.5393794639804851,-1.30293888526574,0.1879432624113475,1.0,1.0,2/10,0.98%,SLC12A2;SLC12A7
prerank,Hsp70 protein binding (GO:0030544),0.5561007622434951,1.3020422389547162,0.16132723112128147,0.6829704405501565,1.0,7/31,13.43%,CYP1A1;ERN1;SNCA;DNAJC8;GPR37;NOD2;STUB1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5886683826295935,1.293764811359821,0.1716686674669868,0.7066951503697427,1.0,6/26,11.32%,LGALS3;MGAT5;SAG;PPP1R11;ENSA;BOD1L1
prerank,Hsp90 protein binding (GO:0051879),0.5505605262963894,1.2934381674326345,0.16397228637413394,0.7018914566551675,1.0,12/33,17.63%,CYP1A1;PTGES3;ERN1;CSNK2A1;HSF1;AHSA1;HDAC6;NOD2;STUB1;CHORDC1;HIF1A;NPAS2
prerank,1-phosphatidylinositol binding (GO:0005545),0.6094066854720835,1.2905866769258714,0.18908122503328895,0.7063758819679542,1.0,8/15,18.27%,SNX9;ZFYVE9;WDFY1;EPB41;FRMPD2;SNX10;WDFY3;PICALM
prerank,chemorepellent activity (GO:0045499),-0.39581457883806,-1.289428914839378,0.11764705882352941,1.0,1.0,8/25,8.24%,SEMA6A;SEMA5A;EPHA7;SEMA6D;SEMA3A;NRG3;SEMA3C;SEMA3D
prerank,MAP kinase phosphatase activity (GO:0033549),0.6388803286241866,1.2858903803172164,0.21598877980364656,0.7180073617056413,1.0,3/12,9.05%,DUSP3;DUSP29;DUSP10
prerank,hexosaminidase activity (GO:0015929),0.6479191161781834,1.2837230547778502,0.22617354196301565,0.7205335544226686,1.0,3/12,7.10%,HEXB;HEXA;OGA
prerank,alanine transmembrane transporter activity (GO:0022858),0.6318503163423359,1.2828419856254574,0.21610738255033557,0.7178684803223153,1.0,6/12,23.68%,SLC7A8;SLC36A1;SLC36A4;SLC1A4;SLC38A7;SLC6A6
prerank,sterol binding (GO:0032934),0.5234320691731,1.2785718641161914,0.1291005291005291,0.7278099749886424,1.0,21/56,21.38%,TSPO;ABCA1;NPC2;ABCG1;OSBPL11;NPC1;SOAT2;ERLIN2;ERLIN1;OSBPL10;GPR183;OSBP;VDAC2;STARD4;VDAC1;OSBPL8;STARD5;GRAMD1C;OSBPL7;STARD3;SCARB2
prerank,insulin-like growth factor I binding (GO:0031994),0.6191200989359054,1.2719793618314585,0.21751025991792067,0.7460686584498191,1.0,2/13,4.11%,ITGB3;ITGA6
prerank,Notch binding (GO:0005112),-0.3968242426030968,-1.2719655221855302,0.16580310880829016,1.0,1.0,13/22,35.57%,CCN3;SNED1;AAK1;SNW1;JAG1;JAG2;NOTCH4;HIF1AN;TCIM;KCTD10;GALNT11;DLL4;DLL1
prerank,phosphatase binding (GO:0019902),0.5017534607227581,1.2674062446821164,0.10786290322580645,0.7574371542752505,1.0,16/105,8.62%,CD22;LGALS3;SIRPA;CTSC;KCNN4;MAPK14;PPP6R1;TRAF2;TRAF3;CTNNB1;CEP192;TP53;MAP3K5;WNK1;MTMR3;SMAD3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5609551600232424,1.2649737215077304,0.21200980392156862,0.7607192929845296,1.0,7/22,18.27%,PCSK9;APOE;LDLRAP1;CLTC;AP2M1;MESD;PICALM
prerank,lipoprotein particle receptor binding (GO:0070325),0.5547506417759619,1.2644314401801466,0.18979833926453143,0.756790475014469,1.0,9/27,20.19%,PCSK9;APOE;LDLRAP1;CLTC;LRP1;AP2M1;MESD;PICALM;RELN
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.46168322659979316,-1.2620573185507915,0.1984732824427481,1.0,1.0,6/15,30.45%,SLC26A2;SLC26A7;SLC39A8;SLC26A6;CFTR;SLC26A8
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.42383175528718053,-1.2616984880470654,0.1703056768558952,1.0,1.0,4/17,4.87%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.42383175528718053,-1.2616984880470654,0.1703056768558952,1.0,1.0,4/17,4.87%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,transcription cis-regulatory region binding (GO:0000976),0.4841101837267792,1.2569915967090055,0.007,0.7794499148066193,1.0,83/406,14.67%,RUNX1;NFE2;NPAS4;MMP12;AHRR;ASCL1;CIITA;GATA1;NFE2L2;POU2F2;BASP1;RREB1;NR1H4;CREB3;BARX2;RXRB;TNF;SNCA;MLXIP;NFXL1;ATF3;FOXO3;CEBPA;DDIT3;SPI1;MAFK;HDAC5;HOXC8;HMGB1;TRPS1;XRCC5;TEAD1;FLI1;CREB3L1;TFEB;ZFP69;ZNF177;ACTN4;TP53;MEF2A;TBL1XR1;NKX2-1;TAL1;LONP1;YY1;SNAI1;ZFP90;CEBPB;FOXN2;MEF2C;CDC5L;TFAP2B;RB1;SMAD3;IRF2;HSF1;ARID4A;HNRNPL;CREBRF;NFX1;HDAC4;TBL1X;RNF10;CREB3L2;RBBP5;SOX9;ETV6;NR2C2;E2F6;ATF6B;SNAPC3;MAX;NFKB1;TIPARP;FOXN3;IRF1;FOXK1;SOX6;CUX1;SOX2;BRD7;SREBF1;SOX4
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6302565335063479,1.2560429062166616,0.24033149171270718,0.7770760200391611,1.0,5/12,15.03%,NAPSA;DDI2;SPPL3;CTSE;SPPL2A
prerank,ribosomal large subunit binding (GO:0043023),-0.48807688015426,-1.2554737247264327,0.1901639344262295,1.0,1.0,6/11,25.58%,CPSF6;NEMF;DHX33;NPM1;NMD3;MRRF
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5593402660165744,1.2551278335664213,0.22287735849056603,0.7744310894707572,1.0,2/23,2.04%,PLCB2;PLCG2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5655686671773409,1.2543029269319983,0.1940828402366864,0.7715068314704928,1.0,8/28,18.56%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2;RPS6KA2;MAP2K5
prerank,insulin-like growth factor binding (GO:0005520),0.6020403801252042,1.2524612136151878,0.2210242587601078,0.7725391748389061,1.0,2/15,4.11%,ITGB3;ITGA6
prerank,peptide hormone receptor binding (GO:0051428),-0.48791357211731823,-1.2520850102216101,0.19855595667870035,1.0,1.0,5/11,34.63%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,endonuclease activity (GO:0004519),0.5058741733870347,1.2512799700933923,0.1814207650273224,0.7710846580786075,1.0,13/49,17.98%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;RNASEL;AGO3;ERCC5;REXO4;OGG1;ZC3H12C;N4BP2;AGO2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6182959502948536,1.2503970307942813,0.2288488210818308,0.7684008129303838,1.0,5/12,12.46%,ARSB;GNS;IDS;SULF2;ARSA
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.33914673455508576,-1.2496440375753208,0.10784313725490197,1.0,1.0,5/38,4.50%,APP;SERPINH1;SERPINE2;SERPING1;TFPI
prerank,glycerophospholipid flippase activity (GO:0140333),0.6275004712880807,1.2479377188609908,0.2397163120567376,0.7718111097391028,1.0,5/11,15.52%,ATP8A1;ATP8A2;ABCB4;ABCA4;ABCA3
prerank,semaphorin receptor activity (GO:0017154),0.6433999282578421,1.2473478491337684,0.2267605633802817,0.768272164630541,1.0,3/11,10.88%,PLXNC1;PLXNB2;NRP1
prerank,calcium channel inhibitor activity (GO:0019855),-0.4968037509459339,-1.2458132418402499,0.21575342465753425,1.0,1.0,4/11,26.85%,FKBP1A;SLC30A1;PACSIN3;CALM2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4000012713329252,-1.2456480102723861,0.14492753623188406,1.0,1.0,4/21,10.17%,CHRFAM7A;CHRNA7;GRM5;GRM1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.5017481589447761,-1.2454837476441727,0.2108626198083067,1.0,1.0,5/11,34.96%,KCND3;KCNJ3;KCNJ8;KCNE4;KCNH2
prerank,protein kinase C binding (GO:0005080),0.5243456297804657,1.245211459041908,0.18599562363238512,0.7705626052569593,1.0,11/43,12.48%,PLEK;PKP2;PRKD2;ADCY6;HDAC5;PRKCB;HINT1;NELL1;PKN1;TWF2;HDAC9
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.619766050298358,1.2420556259017062,0.25755395683453236,0.7769329211127998,1.0,5/11,12.71%,PYCARD;CASP1;CFLAR;CASP7;CASP8
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.4051266562507137,-1.2408963491584266,0.18454935622317598,1.0,1.0,7/18,20.87%,STXBP6;CNN3;BAIAP2L1;BAIAP2;S100A11;ANXA2;PPP1CA
prerank,fatty acid synthase activity (GO:0004312),-0.5019469494732215,-1.238716084528569,0.23890784982935154,0.9907877420567777,1.0,7/10,42.70%,ELOVL5;CBR4;ELOVL1;OXSM;MCAT;ELOVL4;ELOVL2
prerank,ribonuclease activity (GO:0004540),0.49813530577472565,1.238077944985591,0.1864951768488746,0.785691163661585,1.0,20/56,22.25%,SLFN14;ERN1;NOB1;EXOSC1;SAMHD1;SND1;ELAC2;ZC3H12D;RNASEL;AGO3;RNASEH1;ZC3H12C;AGO2;RNASEH2A;EXOSC3;DIS3L2;DICER1;RNASE6;CNOT7;EXOSC2
prerank,protein kinase binding (GO:0019901),0.4779713353522666,1.2377505642288391,0.007,0.7811678791172992,1.0,88/479,12.56%,PTPRC;CD226;TREM2;IRF5;BLNK;FGR;PLEK;CD3E;ITGB2;CASS4;HCLS1;STAP1;LYST;NEFH;MAPKAPK3;SIRPA;LAT;PRKAR2B;PLCG2;GPRC5B;THY1;PTPRJ;PRKCD;MAD2L2;DUSP3;GRB2;PTPN1;RFFL;NEK6;MAP2K6;TRIM5;CCND3;PKP2;PRKD2;GCH1;RGCC;CIR1;TUBA4A;TTN;SKI;TRAF2;DNAJC3;FOXO3;ADCY6;NBEAL2;HDAC5;CCND2;SHC2;PRKCB;USF1;MAP2K3;BCL2L1;CEP192;MAPRE1;ACTB;TP53;WNK1;NEDD9;TICAM1;HINT1;TRAP1;CHEK2;KIF14;AP1B1;TRIM27;SMAD3;MAP3K1;DUSP10;HSF1;IBTK;QARS1;BCAR1;TPR;DUSP19;NELL1;LIMS1;PKN1;SH2B3;CLTC;SOX9;BECN1;ADIPOR1;PRDX3;TWF2;NOD2;MAP3K12;HDAC9;TBL2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6069190957153081,1.2375165658943077,0.22807017543859648,0.7765606328262223,1.0,4/14,10.34%,BLVRB;CRYM;QDPR;PYCR2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.5477448296714336,1.2371701193691527,0.20232558139534884,0.7723204959647317,1.0,12/28,20.92%,EXO1;ENDOV;ELAC2;RPP38;ELAC1;AGO3;RNASEH1;RPP14;PRORP;AGO2;RNASEH2A;DICER1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.5244758921911715,1.2357459746448949,0.20956719817767655,0.7722217515433231,1.0,7/38,8.43%,NCF4;SH3PXD2B;ZFYVE26;ZFYVE28;DENND1A;SNX27;TECPR1
prerank,acid-thiol ligase activity (GO:0016878),-0.4650708110459658,-1.2357298870110078,0.23985239852398524,0.9703891708967851,1.0,6/13,30.09%,ACSL1;ACSS2;ACSS1;SLC27A2;AACS;AASDH
prerank,cytokine receptor binding (GO:0005126),0.4960108741194456,1.2315535560227409,0.14315352697095435,0.7817976798202239,1.0,17/83,13.98%,SYK;TYK2;OSM;IL6R;PYCARD;CD300LF;IL18;VEGFB;EPO;TGFBRAP1;SMAD3;SH2B3;TIMM50;SDCBP;PXDN;PRLR;ERAP1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.30637889581888056,-1.2272006360171879,0.10714285714285714,0.9735894569333655,1.0,28/60,26.27%,ROR1;CRIM1;NTRK3;AXL;EGFR;ALK;EFEMP1;EPHA7;EPHA3;EPHB4;EPHB2;PDGFRA;ROR2;MET;EPHA10;MUSK;TEK;RET;FGFR4;FLT4;LMTK2;NTRK2;NRP2;EPHA6;FGFR3;FGFR2;ERBB3;FGFRL1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5310839680771591,1.2269911438454522,0.2128146453089245,0.7928952510873165,1.0,11/30,22.13%,TNFAIP8;PTTG1;CST7;SNCA;PRDX3;GAS6;PRDX5;UBE2Z;BIRC2;BIRC3;MT3
prerank,leucine zipper domain binding (GO:0043522),0.6302951801241692,1.2262990462533592,0.2772133526850508,0.7899961860873088,1.0,4/10,12.34%,DDIT3;MRTFA;NRL;PMF1
prerank,CoA-ligase activity (GO:0016405),-0.46266767089915717,-1.2257603631209228,0.21568627450980393,0.9499527545212825,1.0,6/14,29.57%,ACSL1;ACSS2;ACSS1;ACSBG1;SLC27A2;AACS
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5251983194767692,1.2255314848017687,0.20310765815760268,0.7872015952455804,1.0,9/35,15.84%,PLD4;PLCB2;SMPD3;PLD3;PLCXD3;PDE11A;GDE1;GDPD3;PDIA3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5747848345034323,1.2247523499934863,0.25191815856777494,0.7845865309026467,1.0,8/18,22.13%,TNFAIP8;SNCA;PRDX3;GAS6;PRDX5;BIRC2;BIRC3;MT3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5508828551409153,1.2238288422537338,0.2658536585365854,0.7827095489710811,1.0,5/22,10.72%,DUSP3;DUSP29;MTMR3;DUSP10;DUSP19
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.5019561016081409,1.2192225696895784,0.19483315392895587,0.7943360340849479,1.0,11/54,14.10%,KLK3;ASPG;PIGL;HDAC5;HINT1;ACER3;HDAC4;HDAC6;HDAC9;DARS1;HDAC11
prerank,kinase inhibitor activity (GO:0019210),0.5282432736755494,1.218130786715423,0.2242562929061785,0.7928918367466941,1.0,7/33,10.72%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;DUSP19
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.47273546495764474,1.2170038446729388,0.1001001001001001,0.7917548039208699,1.0,37/173,13.76%,BATF3;ASCL1;IRF8;BCL11A;ZEB2;SREBF2;MITF;SKI;ATF3;FOXO3;LRRFIP1;ZBTB12;MYT1L;MAFK;ZBTB39;BHLHE41;BACH1;TRPS1;CREB3L1;ZFP69;ZNF177;YY1;SNAI1;ZFP90;CEBPB;GTF2IRD1;HSF1;NFX1;TGIF1;ETV6;JDP2;E2F6;GZF1;MAX;NFKB1;FOXK1;ZFHX3
prerank,actin binding (GO:0003779),0.47443979252125323,1.2158955193756613,0.10120240480961924,0.7901475362805929,1.0,46/170,15.12%,MYO1F;LCP1;SPTBN5;IQGAP2;CORO1A;MYL3;SNCA;GAS2L3;CXCR4;MYH9;SYNE1;MRTFA;FLII;MACF1;MYO9B;CAPZB;MTSS1;ACTN4;KCNMA1;LDB3;TMSB4X;P4HB;MICAL1;CAPZA1;MYO19;TNNT3;CAP1;TLNRD1;VCL;PFN2;MAP1B;MAEA;PARVB;PFN1;TWF2;NOD2;COTL1;TMSB10;SMTN;SSH2;ADCY8;SYNPO;LRRK2;MYH10;PDLIM1;FXYD5
prerank,acylglycerol lipase activity (GO:0047372),0.6093104760435282,1.2158184818106343,0.2545710267229255,0.7852859835979291,1.0,4/11,15.17%,ABHD12;ABHD3;LIPE;ABHD16A
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.39029650137392835,-1.2134329945557911,0.2,0.967120012133449,1.0,8/20,26.01%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;SLC39A12
prerank,serine-type peptidase activity (GO:0008236),0.4780374429280707,1.2123954065494091,0.16767676767676767,0.7923923947773371,1.0,5/96,4.79%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,nuclear receptor coactivator activity (GO:0030374),0.5011623747698764,1.2114812202530971,0.23459459459459459,0.7906779206752861,1.0,20/52,22.34%,BRD8;MED17;TACC1;ZMIZ2;PRKCB;CCAR1;ACTN4;PPARGC1A;RNF4;ACTN1;PKN1;SRA1;BUD31;THRAP3;TMF1;MED4;MED13;SFR1;FGF2;MED30
prerank,retinoid X receptor binding (GO:0046965),0.6185127258170595,1.2114152312853461,0.25358166189111747,0.7858094841354379,1.0,3/11,11.49%,NSD1;TACC1;NRIP1
prerank,CARD domain binding (GO:0050700),0.5848400438582118,1.2100437936414241,0.264945652173913,0.7857968603531639,1.0,4/14,16.24%,CARD11;CASP1;NOD2;IRGM
prerank,DNA polymerase activity (GO:0034061),-0.39194074461576,-1.2079739856418277,0.18579234972677597,0.9601482555797277,1.0,12/22,22.97%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;TERT;POLG;POLE2;POLQ;POLK;POLI
prerank,protein kinase C activity (GO:0004697),0.5893551482341464,1.206408549113865,0.2733516483516483,0.7936057963157186,1.0,6/14,10.98%,PRKCD;PRKCB;PRKCQ;SMG1;PRKCH;PKN1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5692779671510189,1.2015853477377718,0.26988265971316816,0.8052115309493451,1.0,2/16,4.54%,ALOX12;HAAO
prerank,ADP binding (GO:0043531),0.5387049120063507,1.2008063369764597,0.27020506634499397,0.8029682125280038,1.0,9/25,14.14%,ERN1;ABCG1;MYH9;MYO9B;LONP1;ABCD1;TAP1;ATP5F1A;MYH10
prerank,DNA-binding transcription factor binding (GO:0140297),0.46210056727069204,1.197652480870285,0.105,0.8085458756170887,1.0,29/189,8.62%,ASCL1;CIITA;HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;NEK6;TLE3;SKI;DDIT3;SPI1;FIZ1;HDAC5;BHLHE41;HMGB1;TAF1;USF1;CTNNB1;MTA3;TP53;MEF2A;TAL1;MYOCD;LMO2;MEF2C;RB1;SMAD3
prerank,endopeptidase activity (GO:0004175),0.46489143776588543,1.1976159757847997,0.075,0.8036715812874621,1.0,47/257,16.27%,CTSS;KLK3;MMP12;CTSB;PCSK9;NAPSA;F10;LGMN;CTSC;CTSK;CTSL;MASP1;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ESPL1;RHBDF2;CASP1;USP35;DDI2;PSMB10;MALT1;ZMPSTE24;CTSZ;NLN;CTSE;MMP19;USP7;PSMA2;USP48;CASP7;USP18;PARL;CASP8;PCSK7;PSMB5;USP9X;KLK2;ECEL1;USP8;PMPCB;USP29;PSMB9;PDIA3;USP16;RHBDF1;IDE
prerank,syntaxin binding (GO:0019905),0.4841127924294585,1.195808347417415,0.22245762711864406,0.8050174090536169,1.0,15/61,14.11%,SYT17;ABCA1;VAMP3;VPS18;SYT2;STXBP3;CACNA1A;VPS11;SYT10;SNAP29;VPS54;RAB11A;SNAP23;STX8;LRRK2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.2969273234712993,-1.1956988707978804,0.15,0.9788191926516799,1.0,15/60,10.85%,ROR1;NTRK3;AXL;EGFR;ALK;EPHA7;EPHA3;EPHB4;ACVR1;EPHB2;ACVRL1;PDGFRA;ROR2;ACVR1B;MET
prerank,gated channel activity (GO:0022836),0.5763455514401856,1.1941776203150445,0.2682602921646746,0.8054532023031956,1.0,3/14,10.11%,TMC6;PACC1;TMEM63A
prerank,sodium:proton antiporter activity (GO:0015385),0.6001988295942636,1.1929979317457362,0.28512396694214875,0.8048923606044036,1.0,4/11,14.49%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,GABA receptor activity (GO:0016917),-0.3976646225894638,-1.192401891583241,0.19473684210526315,0.9647860333139521,1.0,6/21,10.75%,GABRB2;GABRB1;GABRA2;GPR156;GABBR2;GABRB3
prerank,inward rectifier potassium channel activity (GO:0005242),0.537474748054131,1.190900957752869,0.27294685990338163,0.807755781013592,1.0,2/24,3.24%,KCNJ11;KCNK6
prerank,metalloaminopeptidase activity (GO:0070006),-0.41269539474725025,-1.1901834174546306,0.2510822510822511,0.947284666827814,1.0,7/16,20.55%,LTA4H;MMP14;RNPEPL1;MMP16;NPEPPS;ENPEP;MMP15
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2651583498137915,-1.1880247771688572,0.06060606060606061,0.9304886690673493,1.0,19/82,14.34%,APP;SERPINH1;SERPINE2;CAST;SERPING1;RECK;TFPI;COL4A3;SPOCK2;TIMP2;USP14;TIMP3;BIRC6;NGF;ROCK1;SERPINB9;SERPINF1;UBE2O;BST2
prerank,RNA stem-loop binding (GO:0035613),0.5972484648094525,1.1879412886812721,0.30354609929078014,0.8130251166597287,1.0,6/12,14.14%,DHX9;RC3H2;RC3H1;EPRS1;CPEB3;MYH10
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.45582376437525374,1.1875826338382933,0.02,0.8094351049880341,1.0,104/597,14.82%,RUNX1;BATF3;NFE2;IRF5;AHRR;ASCL1;CIITA;MEOX1;IRF4;IRF8;MCM5;GATA1;NFE2L2;ORC3;POU2F2;BASP1;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;TNF;SNCA;SREBF2;RFX1;ATF3;FOXO3;CEBPA;DDIT3;SPI1;ZBTB12;MAFG;MAFK;HDAC5;HOXC8;BHLHE41;HMGB1;XRCC5;TEAD1;FLI1;USF1;CREB3L1;TFEB;ZNF177;KLF6;TP53;TBL1XR1;NKX2-1;NRL;TAL1;YY1;SNAI1;CEBPB;FOXN2;MEF2C;TFAP2B;SMAD3;GMEB2;ZNF32;IRF2;HSF1;ARID4A;HNRNPL;GMEB1;MCM2;HDAC4;MCM6;TBL1X;NFIC;RNF10;HOXA6;TGIF1;CREB3L2;KLF13;RBBP5;ELF2;SOX9;ORC4;NR2C2;JDP2;ZNF740;HSF5;ATF6B;MCM9;CREB1;KAT7;MAX;NR4A1;NFKB1;IRF1;FOXK1;RFX7;SOX6;CDC6;CUX1;SOX2;BRD7;SREBF1;SOX4;POU6F1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4067223614796578,-1.1841976459290697,0.26422764227642276,0.9209642655708646,1.0,3/16,4.94%,SLC26A2;CLCN6;SLC26A7
prerank,death domain binding (GO:0070513),0.6015047081258494,1.1833602386757858,0.30460624071322434,0.8192757723783279,1.0,5/11,16.24%,BCL2L1;CRADD;DAP;TRADD;IRGM
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5656308251857536,1.1832601797774616,0.28036175710594313,0.8147846506169367,1.0,4/18,12.45%,PIK3R5;WDR91;CCKBR;WDR81
prerank,potassium:proton antiporter activity (GO:0015386),0.6085583196983082,1.181378560588336,0.29814550641940085,0.8163232261712334,1.0,4/10,14.49%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4545792601630125,1.180841117678384,0.13113113113113112,0.8135066603709264,1.0,45/181,17.29%,HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;NR1H4;DHX9;MAPK14;TACC1;SPI1;FIZ1;HDAC5;BHLHE41;TAF1;CTNNB1;MTA3;ACTB;ACTN4;TP53;MEF2A;SETD6;TAL1;MYOCD;LMO2;MDFIC;RB1;SMAD3;ARID1A;PPARGC1A;ANXA4;HDAC4;NRIP1;CREB1;SMARCD3;RERE;SMARCB1;PTPRT;PIAS1;BUD31;MTDH;RBPJ;HIF1A;FAF1;TRIP4;PPARD
prerank,hydro-lyase activity (GO:0016836),0.5010433620214285,1.1783093607843989,0.2679162072767365,0.8172865702605953,1.0,13/41,19.63%,TBXAS1;EHHADH;IREB2;ENO3;HACD4;ECHS1;ACO1;ECI1;CDYL;NAXD;CBS;ECHDC1;ENO1
prerank,glutathione transferase activity (GO:0004364),0.5275097282333034,1.171975822943871,0.2608695652173913,0.8341514895853419,1.0,2/23,3.22%,GSTT4;HPGDS
prerank,kinase binding (GO:0019900),0.4538445758303962,1.1717406630133984,0.05,0.8301683319767251,1.0,91/434,15.65%,PTPRC;CD226;IRF5;BLNK;FGR;CD3E;ITGB2;HCLS1;STAP1;LYST;NEFH;LAT;PLCG2;GPRC5B;THY1;PTPRJ;PRKCD;DUSP3;GRB2;PTPN1;RFFL;PFKL;NEK6;MAP2K6;TRIM5;CCND3;RGCC;CIR1;TUBA4A;TTN;SKI;TRAF2;DNAJC3;FOXO3;CEBPA;ADCY6;CASP1;NBEAL2;WWC2;CCND2;SHC2;USF1;CTNNB1;MAP2K3;BCL2L1;CEP192;MAPRE1;ACTB;TP53;SNAI1;WNK1;TAX1BP1;TICAM1;TRAP1;CHEK2;KIF14;DGKD;AP1B1;TRIM27;RB1;SMAD3;MAP3K1;HSF1;IBTK;QARS1;BCAR1;LIMS1;CLTC;BECN1;PARP16;ADIPOR1;PRDX3;NOD2;MAP3K12;TBL2;EXOC2;STUB1;CEP152;MOB1B;CDC6;NISCH;TRADD;KCNA5;PPP1CC;LRBA;VDAC1;PIH1D1;TBC1D14;SRC;BCAR3;STRADA
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5157271884763763,1.1672812645010933,0.2977461447212337,0.8407891381845765,1.0,12/27,21.76%,SLC11A1;AQP1;ATP2B1;ZDHHC13;ITPR2;ATP2B3;ATP2A3;TMEM165;MMGT1;TUSC3;MAGT1;SLC12A3
prerank,phospholipase C activity (GO:0004629),0.5181267283829292,1.166773771188134,0.30117647058823527,0.8377589968779006,1.0,2/25,2.04%,PLCB2;PLCG2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.40926448422451067,-1.1659726463815088,0.2765957446808511,0.9621342986453795,1.0,3/16,1.32%,MTM1;SACM1L;MTMR7
prerank,receptor ligand activity (GO:0048018),0.45151600811437886,1.1657174221146176,0.131,0.836627362262976,1.0,31/245,14.20%,TSHB;GPNMB;LGALS3;SHH;TGFB1;IL1A;METRNL;SLURP1;MDK;ANGPTL3;OSM;SEMA4D;TNF;TIMP1;IL18;NDP;HMGB1;VEGFB;EPO;PPY;NTF3;INHBA;VGF;SEMA4A;CHGB;ARTN;GRN;NRG1;TAFA1;GAS6;NMB
prerank,double-stranded RNA binding (GO:0003725),0.4674091811506314,1.1652498477981976,0.25622406639004147,0.8336015056570049,1.0,19/70,16.52%,RFTN1;DHX9;TLR7;TLR8;LRRFIP1;RC3H2;EIF4A1;ADAR;RC3H1;AGO4;EIF4H;ACTN1;APTX;CLTC;AGO3;ADARB1;PRKRA;MTDH;TARBP2
prerank,phosphatidic acid binding (GO:0070300),0.5341031587926498,1.1642688153476468,0.3055555555555556,0.8321693607029386,1.0,3/19,6.86%,PLEKHN1;SMPD3;MICALL1
prerank,voltage-gated ion channel activity (GO:0005244),0.569703041483523,1.1636657992597668,0.3302013422818792,0.8297291736857559,1.0,6/14,21.25%,PKD2;VDAC3;VDAC2;VDAC1;HVCN1;HCN1
prerank,protein heterodimerization activity (GO:0046982),0.45038974795910913,1.1624768278568356,0.1675025075225677,0.8291912360073733,1.0,37/178,14.43%,NPAS4;CYBB;CD3E;IRAK2;MLXIPL;ABCG1;ATF3;DDIT3;HEXA;BHLHE41;FZD9;TAF1;USF1;BCL2L1;TP53;MEF2A;P4HB;MEF2C;DGKD;TFAP2B;PAFAH1B2;BAK1;ALG2;HSF1;TPM4;VAPB;METTL3;SDCBP;PPP2CA;IKBKG;KATNA1;NR4A1;ADCY8;ATP1B2;UBA2;MIGA1;SNX2
prerank,cardiolipin binding (GO:1901612),0.5946601251673096,1.162420953605028,0.31718061674008813,0.824887472025249,1.0,1/10,1.46%,PLEKHN1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.45805813547407004,-1.1610196713029013,0.2888086642599278,0.9563242668753907,1.0,7/11,27.32%,TRPC1;ITPR3;RPH3A;TRPC4;TRPC7;TRPC3;CYTH2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.44900954665738263,1.159818823762944,0.142,0.8289139753360633,1.0,45/254,13.35%,RUNX1;NPAS4;IRF5;IRF4;GATA1;NFATC1;RREB1;NR1H4;ELF4;SP7;CREB3;BARX2;RXRB;FOXD2;MLXIP;MITF;ATF3;FOXO3;CEBPA;DDIT3;CREB3L1;KLF6;TP53;MEF2A;NRL;YY1;MEF2C;NKRF;CDC5L;TFAP2B;SMAD3;IRF2;LITAF;CREBRF;GMEB1;NFIC;SOX9;NR2C2;ATF6B;CREB1;SMARCD3;ZNF445;NR4A1;NFKB1;IRF1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3773741954469749,-1.1597628360483219,0.23958333333333334,0.9377437119734369,1.0,11/21,22.97%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;POLG;POLE2;POLQ;POLK;POLI
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.38556954688317924,-1.159383769278216,0.2608695652173913,0.9176518630833352,1.0,7/21,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,solute:anion antiporter activity (GO:0140323),-0.43667454526778693,-1.1560742665519426,0.2872727272727273,0.9086106410979506,1.0,5/14,30.45%,SLC26A2;SLC26A7;SLC4A2;SLC26A6;SLC26A8
prerank,vinculin binding (GO:0017166),-0.4574397911979591,-1.1555568021139564,0.2768166089965398,0.890975922481109,1.0,4/11,9.60%,UTRN;DMD;SORBS3;SYNM
prerank,secondary active transmembrane transporter activity (GO:0015291),0.47552597710179456,1.1549511703505242,0.26997840172786175,0.8408238978628295,1.0,10/51,15.41%,SLC16A10;SLCO2B1;SLC25A16;SLC7A8;SLC16A2;TMEM241;SLC20A2;SLC25A30;SLCO1B1;CLCN4
prerank,protein kinase inhibitor activity (GO:0004860),0.48302913019237614,1.1547932241485204,0.28632938643702904,0.8368879286095403,1.0,8/42,10.72%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;IBTK;QARS1;DUSP19
prerank,kinase activity (GO:0016301),0.45344795813064476,1.1546480209572938,0.23761375126390294,0.8328474254358829,1.0,22/109,14.11%,LYN;PIK3CG;DGKZ;PIK3CD;MTOR;PIK3CB;CHKB;CKB;DGKK;DGKE;TAF1;NADK;CERK;CSNK2A1;DGKD;DGKG;AGK;PAPSS1;POMK;DGKI;SHPK;LRRK2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5733968193121657,1.1523706486571677,0.32653061224489793,0.8357953792679205,1.0,4/12,14.49%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.48680134350526943,1.14937037725087,0.2996594778660613,0.8413535617755131,1.0,16/37,22.53%,VARS1;FARSB;GARS1;RARS1;QARS1;EPRS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;YARS1;TARS1;SARS2;SARS1
prerank,retinoic acid receptor binding (GO:0042974),0.5433583546242001,1.143296724997956,0.31266490765171506,0.8573135603212728,1.0,4/17,11.49%,NSD1;TACC1;ACTN4;NRIP1
prerank,G protein-coupled receptor binding (GO:0001664),0.44346514999452236,1.1422716154404027,0.23517587939698492,0.8562407233588906,1.0,11/132,8.31%,GNA15;ARRB2;GPRC5B;GNAQ;GRK3;GNAZ;SAG;NDP;GNA13;GNA12;PPY
prerank,ATPase regulator activity (GO:0060590),0.48481005454619497,1.14050807126125,0.32323232323232326,0.8577299681890079,1.0,10/38,14.28%,BAG2;FNIP2;FNIP1;ATP5IF1;AHSA1;PFN1;TOR1AIP2;ATP1B3;ATP1B2;BAG1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.4078884019910405,-1.1404015999818526,0.27106227106227104,0.9187328673774295,1.0,3/14,6.17%,SLC25A12;SLC17A6;SLC25A13
prerank,thioesterase binding (GO:0031996),0.5842649690767403,1.1389519153057204,0.3265895953757225,0.8585914036744615,1.0,5/11,17.62%,TRAF2;TRAF3;TRAF5;ARF6;CDC42
prerank,fibroblast growth factor binding (GO:0017134),0.5240756884351544,1.137604152797112,0.3363057324840764,0.8589029708667275,1.0,6/21,17.57%,ITGB3;RPS2;FGFBP3;THBS1;FIBP;SCN5A
prerank,calcium ion binding (GO:0005509),0.43927397597889467,1.1371253115692288,0.139,0.8560014582488078,1.0,51/323,13.46%,MMP12;SHH;SYT17;PCDHB6;LCP1;LPL;SMOC2;TPD52;CABP4;ADAM8;S100B;MASP1;SDF4;IDS;SLC8A1;HPGDS;MAN1C1;SNCA;PKD2;KCNIP2;TTN;MCTP1;RASGRP2;PGS1;ASPH;ANXA1;AIF1;S100A2;AGRN;SYT2;CETN3;TPT1;RASGRP3;ITSN1;SYT10;ITPR2;PDCD6;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1
prerank,amino acid binding (GO:0016597),-0.3323198641931502,-1.1362127443723917,0.25806451612903225,0.9127319850670104,1.0,9/31,20.31%,GRIN3A;GRM7;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;NOS1;ASS1
prerank,phosphatidylinositol binding (GO:0035091),0.4475627043343871,1.1353266260030617,0.28732106339468305,0.8575001233007448,1.0,24/91,18.92%,DENND1C;PLEKHN1;MYO1E;SNX5;THY1;SNX9;SNX24;PLEKHF2;DENND1A;ZFYVE9;SNX27;DENND1B;ITPR2;WDFY1;EPB41;EXOC8;FRMPD2;SNX2;APPL2;SNX13;SNX10;WDFY3;PICALM;TULP3
prerank,histone demethylase activity (GO:0032452),-0.33269146520483056,-1.135026490171439,0.2702702702702703,0.8983612299161869,1.0,10/27,18.10%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM6A;KDM2A;KDM4D;KDM8
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.39392454617966366,-1.1339837190862494,0.30677290836653387,0.8844154379179759,1.0,4/15,9.72%,SLC25A12;SLC17A6;SLC25A13;SLC1A5
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5767265700201057,1.1294477919680759,0.35161744022503516,0.8727342603910748,1.0,3/10,10.12%,NSD1;ASH1L;SETD2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5492627608390894,1.1231099256213954,0.35262449528936746,0.88906087101857,1.0,4/14,19.29%,CAPN15;CAPN2;CAPN3;CAPNS1
prerank,monocarboxylic acid binding (GO:0033293),0.5320409972281368,1.1220832255931124,0.3501259445843829,0.8882469820569978,1.0,2/18,3.51%,NR1H4;PSAP
prerank,alkali metal ion binding (GO:0031420),0.5467086742482093,1.1216602085715126,0.3633879781420765,0.8851294607419429,1.0,3/13,15.00%,KCNJ11;HDAC4;CAPN3
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5799231880991623,1.1196192543723524,0.3703170028818444,0.8873632156738226,1.0,6/10,16.85%,CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5628846380305046,1.1180215917965062,0.3548387096774194,0.8882268007710649,1.0,2/11,14.06%,SLC25A20;SLC25A45
prerank,hormone receptor binding (GO:0051427),0.547983934169178,1.1167585505881914,0.3674293405114401,0.8881317102465645,1.0,1/14,2.14%,TYK2
prerank,ATP hydrolysis activity (GO:0140603),0.47277861085070383,1.1148193924107046,0.34572072072072074,0.8900166335828198,1.0,14/41,17.96%,MYO1E;DHX9;ABCD1;KIF14;MYO19;ATP2B1;KIF20B;TOR3A;DNA2;ABCA4;TOR1A;ABCA3;HSP90AA1;ABCD2
prerank,vitamin D receptor binding (GO:0042809),0.5412339067066341,1.1145951623474364,0.36666666666666664,0.8863853743725393,1.0,7/14,22.34%,MED17;THRAP3;RXRA;TAF11;MED4;MED13;MED30
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5450348558084678,1.1129745744065327,0.35733333333333334,0.8872598868943771,1.0,2/15,7.11%,PIK3R5;CCKBR
prerank,voltage-gated sodium channel activity (GO:0005248),0.5050554632985859,1.1124214100988743,0.37880633373934225,0.8848235175514374,1.0,3/22,4.08%,SCN4B;HCN4;PKD2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3341861286045791,-1.1121933823911276,0.29559748427672955,0.93507735863663,1.0,8/26,14.58%,ABCG2;SLC16A12;SLC16A9;SLC16A11;SLC5A6;SLC16A4;SLC6A11;SLC27A1
prerank,ribosomal small subunit binding (GO:0043024),0.5093832139287903,1.1115673020535681,0.3604806408544726,0.8834651818220058,1.0,7/17,19.02%,PIM1;ERAL1;LARP1;EIF1;EIF4H;CPEB2;MTIF3
prerank,phosphatidate phosphatase activity (GO:0008195),0.5509691425659926,1.1104992511573897,0.3923705722070845,0.882816535886518,1.0,2/13,8.70%,LPIN2;PLPPR1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.5662997049952023,1.1101416328866882,0.391304347826087,0.8798057908269765,1.0,1/11,1.74%,NEIL2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.47749216939092026,1.1095755011951927,0.3474285714285714,0.8776256985085081,1.0,11/32,23.68%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC1A4;SLC43A1;SFXN2;SLC38A7;SLC6A6
prerank,semaphorin receptor binding (GO:0030215),-0.3446274487123237,-1.1063692192419263,0.2736842105263158,0.9359485691973001,1.0,6/23,8.24%,SEMA6A;SEMA5A;SEMA6D;SEMA3A;SEMA3C;SEMA3D
prerank,acetylation-dependent protein binding (GO:0140033),-0.3678180581436422,-1.1049414455810822,0.2926829268292683,0.9058168231885096,1.0,6/20,7.68%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,lysine-acetylated histone binding (GO:0070577),-0.3678180581436422,-1.1049414455810822,0.2926829268292683,0.9058168231885096,1.0,6/20,7.68%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,ubiquitin protein ligase binding (GO:0031625),0.42746213041675846,1.1047897578982795,0.228,0.8891047046829823,1.0,59/254,17.86%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;NEK6;SNX9;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ERLIN2;ATXN3;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;TRAF5;VCL;USP7;GPR37;RNF40;BECN1;HDAC6;GPI;NLK;PRKACB;SPOP;TNFRSF1B;DET1;PRDX6;CASP8;IKBKG;STUB1;BAG1;WFS1;UBE2J2;SLF2;HIF1A;RTN4;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N;SCN5A;UBE2K
prerank,nuclear receptor binding (GO:0016922),0.43165665629177763,1.1046759696719881,0.3232016210739615,0.8853078202733189,1.0,34/111,19.53%,BRD8;GAS2L1;MED17;GTF2H1;NR1H4;NSD1;TACC1;TAF1;PRKCB;CTNNB1;ACTN4;MMS19;SMAD3;ARID1A;PPARGC1A;STRN;STAT5B;PKN1;NRIP1;SMARCD3;NR4A1;BUD31;THRAP3;YWHAH;HIF1A;TMF1;GTF2B;TRIP4;KDM4C;RXRA;TAF11;MED4;MED13;DCAF1
prerank,glycine binding (GO:0016594),-0.43541463778923095,-1.1043801201667494,0.35714285714285715,0.8915954322045692,1.0,4/11,18.08%,GRIN3A;GRIN2B;GRIN1;GLRB
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3661904043203343,-1.1027171890785308,0.2897196261682243,0.8804466371997193,1.0,6/18,9.16%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1;ACVR1B
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5587597963058999,1.0990819153795475,0.39552238805970147,0.8994713408442819,1.0,4/10,12.71%,CASP1;CFLAR;CASP7;CASP8
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4546570308672411,1.0981660625071223,0.352112676056338,0.8982650093718194,1.0,10/47,13.29%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC43A2;SLC36A4;SLC66A1;SLC38A10
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.48433567369863323,1.0979443130907174,0.34941176470588237,0.8948286394316489,1.0,3/30,4.80%,SLC11A1;ATP7A;SLC25A37
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4291632665871571,-1.096762799140677,0.34532374100719426,0.8839307801370319,1.0,9/11,57.11%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,calcium activated cation channel activity (GO:0005227),0.5077680438497301,1.0914390372060778,0.38320209973753283,0.9119114372354035,1.0,3/17,10.11%,KCNN4;KCNMA1;TMEM63A
prerank,ATPase binding (GO:0051117),0.4400608704892182,1.086528327229205,0.3605015673981191,0.9233466162796174,1.0,24/71,18.29%,ABCA1;TCIRG1;PKD2;FBL;ATP6V1E1;ALDOB;ATP6V0A2;ATXN3;SVIP;ATP5IF1;DERL1;TMTC4;ATP6V0A1;TOR1AIP2;ATP1B3;ATP1B2;WFS1;PIH1D1;SRC;NUFIP1;ZNHIT6;ANK1;SNX10;PTPN3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5640007019277944,1.0843724161174393,0.4,0.9261461900873718,1.0,2/10,3.74%,SIRPA;PKP2
prerank,NADPH binding (GO:0070402),-0.4115157204264026,-1.0839901866714667,0.3285198555956679,0.9098179034727257,1.0,10/13,34.49%,HMGCR;DUS2;MTRR;CBR4;LBR;DHFR;NDOR1;CRYZ;CBR3;GRHPR
prerank,calcium channel regulator activity (GO:0005246),-0.2946555633357294,-1.0815664004724044,0.3069306930693069,0.9020811226782147,1.0,10/37,26.85%,SRI;FKBP1A;PRKG1;SLC30A1;CACNG8;REM1;PACSIN3;CACNB3;NRXN2;CALM2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41481727155445564,1.0812687982407514,0.153,0.932147939555373,1.0,118/731,13.76%,RUNX1;BATF3;NFE2;NPAS4;IRF5;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;NR1H4;BCL11A;NSD1;MLXIPL;ELF4;ZEB2;DHX9;SP7;CREB3L4;CREB3;RXRB;FOXD2;DNMT3A;SREBF2;MLXIP;RFX1;MITF;BPTF;ZFP30;SKI;ATF3;FOXO3;CEBPA;DDIT3;SPI1;LRRFIP1;ZBTB12;PGBD1;MYT1L;MAFG;HIVEP3;MAFK;ZBTB39;HDAC5;BHLHE41;BACH1;TEAD1;USF1;CREB3L1;CCAR1;TFEB;KLF6;TP53;MEF2A;NKX2-1;NRL;TAL1;YY1;SNAI1;STAT4;CEBPB;ST18;MEF2C;NKRF;TFAP2B;CIART;SMAD3;GMEB2;GTF2IRD1;ZNF32;ZFP14;IRF2;HSF1;LITAF;STAT5B;GMEB1;NFE2L1;HDAC4;ZNF83;NFIC;HOXA6;TGIF1;CREB3L2;KLF13;TRIM24;ZSCAN26;SOX9;OLIG1;HDAC6;NRIP1;NR2C2;JDP2;ZNF740;E2F6;ZNF628;HSF5;GZF1;ATF6B;SNAPC3;CREB1;MAX;ZNF445;ZSCAN18;NR4A1;NFKB1;IRF1;FOXK1;RFX7;SOX6;ZFHX3
prerank,alpha-tubulin binding (GO:0043014),0.47774056682155824,1.079307357515818,0.39669421487603307,0.9345743134985368,1.0,16/31,24.58%,TBCEL;SNCA;DIP2B;ARL8A;SETD2;HDAC6;FYN;INO80;EML4;ARL8B;TAOK1;CDK5R1;TTLL7;ARL4C;DNAL1;FNTA
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4098575063636715,-1.079232182974187,0.37786259541984735,0.8939569736524051,1.0,4/14,16.33%,SLC26A2;SLC26A7;SLC25A14;SLC25A11
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5098668352520553,1.07845499910939,0.40254777070063696,0.9332138255844795,1.0,1/17,0.33%,PTK2B
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.41389620477729,1.077973003922421,0.168,0.9306020331053382,1.0,117/732,13.76%,RUNX1;BATF3;NFE2;NPAS4;IRF5;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;NR1H4;BCL11A;NSD1;MLXIPL;ELF4;ZEB2;DHX9;SP7;CREB3L4;CREB3;RXRB;FOXD2;DNMT3A;SREBF2;MLXIP;RFX1;MITF;BPTF;ZFP30;SKI;ATF3;FOXO3;CEBPA;DDIT3;SPI1;LRRFIP1;ZBTB12;PGBD1;MYT1L;MAFG;HIVEP3;MAFK;ZBTB39;HDAC5;BHLHE41;BACH1;TEAD1;USF1;CCAR1;TFEB;KLF6;TP53;MEF2A;NKX2-1;NRL;TAL1;YY1;SNAI1;STAT4;CEBPB;FOXN2;ST18;MEF2C;NKRF;TFAP2B;CIART;SMAD3;GMEB2;GTF2IRD1;ZNF32;ZFP14;IRF2;HSF1;LITAF;STAT5B;GMEB1;NFE2L1;HDAC4;ZNF83;NFIC;HOXA6;TGIF1;KLF13;ZSCAN26;SOX9;OLIG1;HDAC6;NRIP1;NR2C2;JDP2;ZNF740;E2F6;ZNF628;HSF5;GZF1;ATF6B;SNAPC3;CREB1;ZNF445;ZSCAN18;NR4A1;NFKB1;TIPARP;FOXN3;IRF1;FOXK1;RFX7;SOX6;ZFHX3
prerank,ATP binding (GO:0005524),0.4166910545792728,1.0766903334438187,0.316,0.93061371190682,1.0,67/266,20.15%,MYO1F;BTK;KCNJ11;ABCA1;MAP4K1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;NEK6;ERN1;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;PIM1;LONP1;MAP3K5;WNK1;ABCD1;KIF14;TRIP13;STK17B;MCM6;TAP1;EIF2B2;CARS2;RPS6KA4;NLK;PRKACB;CDK6;TWF2;ATP5F1A;STK3;UBA2;MYH10;DARS2;WNK4;NIM1K;PTPA;ERCC6;IDE;GCK;STK4;TAP2;HSP90AA1;KSR1;RPS6KA5;SIK2;N4BP2;ABCD2;TAOK1;MINK1;TOP1;PYGL;SMC4;TLK2;MAP4K4;P2RY1;ABCA2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4313857087195424,1.0746323781435543,0.3795620437956204,0.9329197237951317,1.0,15/70,19.77%,HEXB;LFNG;GCNT1;HEXA;CHSY3;B4GALT1;POGLUT2;POGLUT1;B3GALNT1;CHSY1;LARGE1;B4GALNT1;MGAT4B;CHPF;GXYLT1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.40608913998744506,-1.072948653075955,0.35251798561151076,0.8970935354808202,1.0,12/12,59.43%,OPN3;GPR88;ELOVL4;GPR52;RRH;OPN1MW;OPN1MW3;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5405051449344713,1.0721665815022767,0.41543026706231456,0.9364185931718425,1.0,3/10,6.95%,TNFAIP3;ATXN3;STAMBPL1
prerank,transforming growth factor beta binding (GO:0050431),0.4840754152516514,1.072030025797556,0.40572792362768495,0.9327140904741638,1.0,7/23,15.32%,NRROS;TGFBR1;TGFBR2;THBS1;VASN;LTBP3;CD36
prerank,ribosome binding (GO:0043022),0.4396842220131159,1.0718911575557433,0.388646288209607,0.9291167289176743,1.0,19/46,25.55%,SLFN14;YTHDF3;TMEM147;CPEB3;NOMO1;SRP19;CPEB4;CCDC47;CPEB2;MTIF3;SERBP1;PYM1;NAA15;EIF3C;RACK1;EFL1;EIF2S1;EIF2A;C1QBP
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4144357888519869,1.0713239573859283,0.293,0.9268307330095925,1.0,61/269,17.86%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;NEK6;SNX9;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ERLIN2;ATXN3;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;TRAF5;VCL;USP7;GPR37;RNF40;BECN1;HDAC6;GPI;NLK;PRKACB;SPOP;TNFRSF1B;DET1;PRDX6;CASP8;ITCH;IKBKG;STUB1;BAG1;WFS1;UBE2J2;SLF2;HIF1A;RTN4;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;TRIP4;UBE2N;SCN5A;UBE2K
prerank,nuclear localization sequence binding (GO:0008139),-0.3626155618225095,-1.0705796706647772,0.3511111111111111,0.8891306099427927,1.0,9/18,31.17%,IPO5;NUP153;RANBP6;NFKBIA;CABP1;TNPO2;KPNA2;POM121;KPNA6
prerank,transmitter-gated ion channel activity (GO:0022824),-0.3233929646424262,-1.070245735307031,0.3333333333333333,0.8758698440835255,1.0,6/29,10.75%,GABRB2;GRIK4;GRIA2;GABRB1;GABRA2;GABRB3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4110777491033033,-1.07014785158227,0.3754646840148699,0.8624380589799372,1.0,5/12,5.30%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1
prerank,microtubule minus-end binding (GO:0051011),0.5256826985385971,1.0659188074314774,0.42536327608982827,0.9400997509677131,1.0,4/13,15.69%,MACF1;TUBGCP4;TUBGCP6;CAMSAP2
prerank,potassium channel activity (GO:0005267),0.42512929566730556,1.065680161468649,0.3987667009249743,0.9367790952366444,1.0,10/89,7.61%,KCNJ11;AQP1;HCN4;KCNN4;KCNK6;PKD2;CCDC51;TMEM38A;KCNMA1;KCNK13
prerank,hexosyltransferase activity (GO:0016758),0.41805258695595415,1.0655492619026485,0.3819655521783181,0.9331365751793969,1.0,17/101,12.55%,HEXB;PIGM;LFNG;GCNT1;HEXA;GYG1;CHSY3;B4GALT1;PIGV;POGLUT2;GBE1;POGLUT1;B3GALNT1;FUT9;TMTC4;CHSY1;B4GALT7
prerank,exonuclease activity (GO:0004527),-0.2738540241496964,-1.0626984695684574,0.2564102564102564,0.8705738705738705,1.0,20/46,24.09%,REV3L;FAN1;MRE11;ENPP3;ERI1;EXOSC7;APLF;WRN;ISG20L2;EXD2;EXOSC8;APEX2;ZC3H12A;EXOG;EXOSC9;POLG;ENPP2;DCLRE1B;EXD1;EXOSC5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.38752380577321865,-1.0568802389800411,0.34576271186440677,0.8744137043629431,1.0,3/13,6.49%,CDH5;BMP4;BMP5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5198771794988749,1.0566459808820718,0.42935528120713307,0.9574158288688596,1.0,5/14,13.85%,MINDY4;ATXN3;USP7;MINDY1;USP9X
prerank,ion channel inhibitor activity (GO:0008200),0.46130874131670463,1.056235342627573,0.42592592592592593,0.954597109766543,1.0,7/35,15.90%,PCSK9;WNK1;ENSA;NEDD4L;STX8;WNK4;RASA1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5051942413554299,1.0560239826018163,0.43253968253968256,0.9512471442731769,1.0,1/15,1.53%,SH3PXD2B
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.404190048604111,1.0538708778932933,0.248,0.9538710615846018,1.0,130/831,13.82%,RUNX1;BATF3;NFE2;NPAS4;IRF5;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;NR1H4;BCL11A;NSD1;MLXIPL;ELF4;ZEB2;DHX9;SP7;CREB3L4;CREB3;BARX2;RXRB;FOXD2;DNMT3A;SREBF2;MLXIP;RFX1;MITF;BPTF;ZFP30;SKI;NFXL1;ATF3;FOXO3;CEBPA;DDIT3;SPI1;LRRFIP1;ZBTB12;PGBD1;MYT1L;MAFG;HIVEP3;MAFK;ZBTB39;HDAC5;HOXC8;BHLHE41;BACH1;TRPS1;TAF1;TEAD1;USF1;CCAR1;TFEB;ZFP69;ZNF177;KLF6;ACTN4;TP53;MEF2A;NKX2-1;NRL;TAL1;YY1;SNAI1;ZFP90;STAT4;CEBPB;ST18;MEF2C;NKRF;CDC5L;TFAP2B;CIART;RB1;SMAD3;GMEB2;GTF2IRD1;ZNF32;ZFP14;IRF2;HSF1;LITAF;STAT5B;CREBRF;GMEB1;NFE2L1;NFX1;HDAC4;ZNF83;NFIC;HOXA6;TGIF1;KLF13;ZSCAN26;SOX9;OLIG1;ETV6;HDAC6;NRIP1;NR2C2;JDP2;ZNF740;E2F6;ZNF628;HSF5;GZF1;ATF6B;SNAPC3;CREB1;MAX;ZNF445;ZSCAN18;NR4A1;NFKB1;IRF1;FOXK1;RFX7;SOX6;ZFHX3;CUX1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.43517698502772445,1.0532573394052893,0.41792656587473004,0.9517492770719626,1.0,16/44,22.77%,SMYD5;NSD1;CXXC1;ASH1L;DOT1L;SETD2;RBBP5;TTLL12;SMYD3;SUV39H1;SETD1B;WDR82;EED;SETD5;NSD3;SETDB1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4235713889657632,-1.0527287495122675,0.38831615120274915,0.8726959834619505,1.0,6/11,42.99%,SLC5A3;SLC5A11;SLC2A9;SLC23A2;SLC23A1;SLC2A10
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.519370964476977,1.0466235502466479,0.4311050477489768,0.9687859352317546,1.0,4/13,14.08%,EXO1;ENDOV;DNA2;SLX4
prerank,carboxylic acid binding (GO:0031406),-0.2994830937170991,-1.0456849173640412,0.3176470588235294,0.879826126728187,1.0,11/38,19.61%,GRIN3A;GRM7;UBR2;SESN3;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;HIF1AN;NOS1
prerank,death receptor binding (GO:0005123),-0.3606082978307772,-1.0452761054825237,0.3654618473895582,0.8682515160113924,1.0,6/15,20.81%,EDA;DAB2IP;NGF;TMBIM1;BDNF;MADD
prerank,GTPase binding (GO:0051020),0.4078353772273271,1.0445620367842947,0.40320962888665995,0.9712402345587993,1.0,56/194,20.55%,FGD2;LCP1;UNC13D;ABCA1;IQGAP2;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;CHML;ARHGAP1;EPRS1;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BECN1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;FNBP1L;GGA2;LRRK2;TMEM127;RNF152;RASA1;ALS2;RABGEF1;HSP90AA1;ARFIP2;NOX1;ARHGEF2;IQGAP1;LAMTOR1;MYO1C;PICALM;ATG14;RAB29;OPTN;DNM1L;ENO1;KIF3A;FMNL1;LZTR1;AIMP1
prerank,protein serine/threonine kinase activity (GO:0004674),0.4055794860812794,1.04429697258856,0.381,0.968052238235519,1.0,72/334,16.57%,PTK2B;SYK;MAPKAPK3;IRAK2;MAP4K1;TAOK3;TGFBR1;PRKCD;CAMK1D;MTOR;BMP2K;MAPK14;GRK3;NEK6;CDK14;ERN1;PRKD2;TTN;MYLK3;CDK8;MAP3K14;RPS6KC1;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;PIM1;MAP3K5;WNK1;PLK4;PIM2;PLK2;CSNK1G2;TNIK;SRPK3;ATP23;CHEK2;PRKCQ;CSNK2A1;CSNK2A2;MAP3K1;CASK;SMG1;CDK7;PRKCH;STK17B;FAM20C;STK32C;PKN1;RPS6KA4;NLK;ALPK1;CSNK1A1;CDK6;MAP3K12;BRAF;STK24;STK3;LRRK2;GAK;WNK4;NIM1K;TESK2;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11;STK4
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.3924919502778251,-1.0439084706643884,0.4150197628458498,0.8597016471563246,1.0,4/13,8.86%,GDI2;GDI1;GPSM2;GPSM1
prerank,heme binding (GO:0020037),0.4212753507178973,1.0421069857082386,0.4392819429778247,0.9711797110374879,1.0,13/65,20.86%,TBXAS1;CYBB;BACH1;CYB5A;CYB561D2;PXDN;SRC;CBS;SDHD;PTGES2;PGRMC1;THAP4;HMOX2
prerank,endopeptidase activator activity (GO:0061133),0.5365639494061323,1.0412159875085474,0.45961820851688695,0.9697882122976618,1.0,2/10,12.57%,VSIR;PSME3
prerank,estrogen receptor binding (GO:0030331),0.44832652128673584,1.0411504145682617,0.45558086560364464,0.9659724086955708,1.0,6/32,11.49%,NSD1;TACC1;CTNNB1;MMS19;STRN;NRIP1
prerank,BMP receptor binding (GO:0070700),-0.3875278649029955,-1.0410247367539096,0.39144736842105265,0.8556845869350338,1.0,3/12,6.49%,CDH5;BMP4;BMP5
prerank,small GTPase binding (GO:0031267),0.4052226373350685,1.0402542300894726,0.41624874623871616,0.9646097820463623,1.0,46/169,20.52%,FGD2;UNC13D;ABCA1;IQGAP2;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;CHML;ARHGAP1;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;GGA2;LRRK2;TMEM127;RNF152;ALS2;RABGEF1;ARFIP2;NOX1;ARHGEF2;IQGAP1;MYO1C;PICALM;RAB29;OPTN;DNM1L;KIF3A;FMNL1;LZTR1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5124083379572003,1.0380276395450365,0.44037940379403795,0.9675497352004006,1.0,2/12,10.11%,TMC6;TMEM63A
prerank,protein phosphatase regulator activity (GO:0019888),0.42896073381459066,1.0378268404475244,0.44537815126050423,0.9641739188299819,1.0,8/53,11.87%,LGALS3;MGAT5;PPP6R1;SAG;ENSA;BOD1L1;RCAN1;PPP4R4
prerank,metalloexopeptidase activity (GO:0008235),-0.2667402823980798,-1.0377080739763533,0.359375,0.8528198551464203,1.0,19/51,25.91%,AGBL4;LTA4H;MMP14;FOLH1;CPM;CPQ;ACE;RNPEPL1;MMP16;NPEPPS;CPXM2;CPD;CPXM1;ENPEP;MMP15;AGBL1;ACE2;CPA6;CPE
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3623948460743396,-1.0369816182653346,0.39215686274509803,0.8435154188231165,1.0,6/18,10.56%,FAR1;AKR1B1;ALDH2;ALDH1A1;ALDH3A2;ALDH1A2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.48538639657894656,1.0358271385307274,0.4577181208053691,0.9663262364161359,1.0,3/17,6.05%,ABCA1;ABCG1;ABCB4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3015494537443447,-1.0350753273219888,0.3898305084745763,0.8370614994980478,1.0,6/29,9.72%,SLC25A12;SLC26A2;SLC26A7;SLC25A13;SLC25A14;SLC1A5
prerank,calcium-activated potassium channel activity (GO:0015269),0.5213777482648628,1.03480813354054,0.4489510489510489,0.9655217289125329,1.0,2/11,6.99%,KCNN4;KCNMA1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4085213040825929,-1.0344194097514288,0.4249201277955272,0.827749039830258,1.0,3/11,4.48%,RYR2;RYR3;ITPR3
prerank,phosphate ion binding (GO:0042301),-0.4219162446272753,-1.034156167210486,0.4423076923076923,0.8175477823153485,1.0,5/10,20.33%,ADSS2;RELA;RPH3A;PDE2A;MTHFD2
prerank,LRR domain binding (GO:0030275),0.4964542653004417,1.0327727281429275,0.44398907103825136,0.9678374100753063,1.0,4/14,12.34%,DDIT3;MRTFA;NRL;PMF1
prerank,outward rectifier potassium channel activity (GO:0015271),0.5265008752680429,1.0322525736919164,0.4603616133518776,0.9656074652930903,1.0,4/11,13.94%,PKD2;KCNIP2;KCNT1;KCNA5
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.39817100697219326,1.0313858409901389,0.396,0.9643709344737511,1.0,104/431,20.15%,MYO1F;TUBB;TUBB1;BTK;KCNJ11;ABCA1;MAP4K1;ABCC6;TGFBR1;RAB39A;P2RX7;RAB32;MTHFS;DHX9;PFKL;NEK6;RAP2A;ERN1;TUBB3;ATP7A;GCH1;ABCG1;TUBA4A;PI4K2A;RAB14;MYH9;RAP1B;RAB7A;P2RX4;TLK1;ARL8A;MYO9B;MKNK1;CDK11B;DNM2;PIM1;LONP1;MAP3K5;WNK1;ABCD1;RAP2B;RAB28;KIF14;TRIP13;RAB31;ARL5B;ARL4A;STK17B;MCM6;RAB1B;TAP1;EIF2B2;CARS2;RPS6KA4;GBP3;ATL1;NLK;PRKACB;CDK6;TWF2;ATP5F1A;RRAS2;STK3;LRRK2;ARF6;UBA2;MYH10;TSR1;RAP1A;DARS2;WNK4;NIM1K;TUBB6;PTPA;ERCC6;IDE;ARL8B;RAB27B;GCK;STK4;TAP2;HSP90AA1;ARFIP2;KSR1;RPS6KA5;SIK2;CDC42;RHOA;N4BP2;ABCD2;MTG2;TAOK1;ATL2;MINK1;TOP1;RHOD;RAB29;PYGL;SMC4;TLK2;MAP4K4;ATL3;P2RY1;ABCA2
prerank,gamma-tubulin binding (GO:0043015),-0.3207435139905971,-1.0292556505185444,0.3979591836734694,0.8196138323041876,1.0,8/21,14.90%,DIXDC1;PAK1;TUBGCP2;CDK5RAP2;BRCA2;NDRG1;MARK4;BLOC1S2
prerank,death receptor activity (GO:0005035),0.5209065192727963,1.028220257771215,0.4479315263908702,0.9702655564039606,1.0,3/11,18.82%,TNFRSF11A;TNFRSF1B;EDA2R
prerank,cAMP binding (GO:0030552),-0.40561704774292573,-1.0269119773129005,0.42524916943521596,0.8151422745331376,1.0,4/11,16.22%,PDE10A;RAPGEF4;RAPGEF2;PDE2A
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4514386466854287,1.0263416454441379,0.4511627906976744,0.9718830785848618,1.0,6/27,14.49%,SLC9A4;SLC8A1;SLC9A9;SLC9A1;SLC8B1;SLC9A8
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4560198902624937,1.0239501550336594,0.4612676056338028,0.9750773629790834,1.0,6/28,9.83%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,double-stranded DNA binding (GO:0003690),0.39308196165022746,1.0228671668719536,0.43,0.9743866898132535,1.0,73/531,14.82%,BATF3;NFE2;IRF5;ASCL1;MEOX1;IRF4;IRF8;GATA1;PCID2;AIM2;POU2F2;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;SREBF2;RFX1;ATF3;FOXO3;ZBTB12;MAFG;HOXC8;BHLHE41;HMGB1;XRCC5;TEAD1;FLI1;USF1;CREB3L1;TFEB;ZNF177;KLF6;NRL;YY1;SNAI1;CEBPB;FOXN2;MEF2C;TFAP2B;GMEB2;ZNF32;IRF2;HSF1;GMEB1;NFIC;HOXA6;TGIF1;KLF13;APTX;ELF2;SOX9;NR2C2;JDP2;ZNF740;HSF5;MBD1;ATF6B;CREB1;MAX;ZNF445;NR4A1;FOXK1;RFX7;CUX1;SREBF1;SOX4;RAD51B;POU6F1
prerank,protein homodimerization activity (GO:0042803),0.39289820683995313,1.0219928787739925,0.406,0.9729922802483727,1.0,124/589,17.28%,LILRB1;SLC11A1;PLEK;IRAK2;LPL;TPD52;CORO1A;PEX11A;CSF1R;RPE;RABEP1;DUSP29;MLXIPL;S100B;MASP1;HPGDS;SNX9;PSAP;CST7;TRIM5;ERN1;ATG7;CRYM;APOE;PKD2;GCH1;ABCG1;PIP4K2A;IL6R;ATF3;CEBPA;DDIT3;ATIC;LRRFIP1;PYCARD;GYG1;COQ9;MYH9;MUC13;XDH;NDP;BHLHE41;TBC1D22A;SYNE1;FZD9;USF1;MYO9B;CDA;BCL2L1;TYROBP;STK10;ACTN4;MAP3K5;TMEM192;PON3;KLHL7;ABCD1;DPY30;CEBPB;KYNU;CHEK2;DGKD;KIF20B;TFAP2B;TRIM27;ATP5IF1;SMAD3;PAFAH1B2;BAK1;PDCD6;SPPL3;TPM4;EPRS1;VAPB;F11R;TRIM8;TPR;ACTN1;NAALADL1;TAP1;ZDHHC3;SLC8B1;PAPSS1;RNF40;GBP3;MID2;PTPRO;PEX7;TPST1;MAP3K12;DEFA6;IKBKG;B2M;MMUT;STUB1;ADCY8;SOX6;CUBN;LRRK2;MIGA1;PTPRT;SNX2;CADM1;DARS2;PRKRA;SPPL2A;PTPA;ERCC5;PSMD7;PDCD6IP;TOP2A;ALS2;DCK;ZBTB7B;TARS2;IDE;MAP3K11;TARBP2;STK4;APPL2;HSP90AA1;CBS;GALM;CPOX
prerank,sequence-specific DNA binding (GO:0043565),0.3919831636510557,1.0217617715980205,0.407,0.9699274071864421,1.0,86/590,14.82%,BATF3;NFE2;IRF5;MMP12;ASCL1;MEOX1;IRF4;IRF8;GATA1;NFE2L2;POU2F2;NFATC1;HES7;NR1H4;ELF4;ZEB2;CREB3L4;CREB3;BARX2;RXRB;FOXD2;CXXC1;SREBF2;TET3;RFX1;BPTF;ATF3;FOXO3;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;XRCC5;TAF1;TEAD1;FLI1;USF1;CREB3L1;TFEB;ZNF177;KLF6;MEF2A;NRL;LONP1;YY1;SNAI1;CEBPB;FOXN2;MEF2C;TFAP2B;SMAD3;GMEB2;ZNF32;IRF2;HSF1;SMG1;PPARGC1A;GMEB1;HDAC4;NFIC;HOXA6;TGIF1;KLF13;ELF2;SOX9;NR2C2;JDP2;ZNF740;STN1;HSF5;GZF1;MBD1;ATF6B;CREB1;MAX;NR4A1;SAFB2;FOXK1;RFX7;CUX1;SOX2;HNRNPD;SREBF1;SOX4;POU6F1
prerank,GTPase activity (GO:0003924),0.39739916097183275,1.0212124833613403,0.46138415245737213,0.9678098139433692,1.0,51/192,19.96%,GNA15;RAB8B;RAB32;GNAQ;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;RAP2B;RAB28;GPN1;RAB31;RAB11A;ARHGDIB;RAB1B;GBP3;ATL1;ABCA4;SAR1A;RRAS2;MMUT;RAB33B;LRRK2;TSR1;GNAI3;RAP1A;GNB5;IRGM;ARL8B;RAB27B;CDC42;RHOA;MTG2;GNAI2;ATL2;RHOD;RAB29;DNM1L;MFN1;ATL3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4270749903285026,1.0200915412173055,0.49002217294900224,0.9672199280624196,1.0,5/46,4.82%,HEXB;MGAT5;LFNG;GCNT1;HEXA
prerank,potassium ion antiporter activity (GO:0022821),0.49150403051968083,1.0184471487976121,0.47606382978723405,0.9681910342123081,1.0,3/15,7.13%,SLC9A4;SLC9A9;SLC9A1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.31080060623832306,-1.0176001457157562,0.3710691823899371,0.8288375257147345,1.0,10/26,25.91%,AGBL4;FOLH1;CPM;CPXM2;CPD;CPXM1;AGBL1;ACE2;CPA6;CPE
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4979957885673871,1.0139838426121424,0.48202396804260983,0.9773599843577538,1.0,4/14,13.62%,PYCARD;CASP1;APAF1;ATP2A3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3857261889458973,-1.013947532075369,0.4181184668989547,0.8282028039642253,1.0,5/12,11.44%,PHF2;JMJD1C;KDM3A;KDM4B;KDM4A
prerank,symporter activity (GO:0015293),-0.4032241905973579,-1.0138220602601236,0.4456140350877193,0.8183018648331677,1.0,9/10,57.14%,SLC5A6;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC5A8;SLC28A3;SLC28A1;SLC5A12
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.46603543891269816,1.012704224209959,0.4833948339483395,0.9737132229769162,1.0,6/21,16.02%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.46603543891269816,1.012704224209959,0.4833948339483395,0.9737132229769162,1.0,6/21,16.02%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,ubiquitin protein ligase activity (GO:0061630),0.39163562384258765,1.0126524582272207,0.479,0.9701932446944708,1.0,55/228,18.54%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;RNF111;PPP1R11;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;UBE4B;NFX1;NEDD4L;TRIM56;RNF10;TRIM24;TRIM35;RNF216;ITCH;RNF135;STUB1;RNF144B;DTX4;HUWE1;AREL1;NEURL1B;NEURL3;ZNRF1;RNF152;SMURF1;TRIM62;FANCL;ANAPC11;ZNRF3;CDC42;UBE2K;BIRC2;FBXO44
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40015740916415043,-1.0116770152872663,0.4440993788819876,0.813881666735449,1.0,4/11,16.23%,DAB2IP;TRAF6;ROR2;PPEF2
prerank,GTPase inhibitor activity (GO:0005095),0.4998256147466569,1.0092479998096984,0.47950819672131145,0.9763261915309516,1.0,4/13,17.26%,IQGAP2;GPS2;CPEB2;IQGAP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.4935499977429303,1.0014189402078562,0.4799482535575679,0.9948219523035392,1.0,2/14,6.72%,NUDT17;NUDT4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.38659592102128665,0.9994330385570751,0.512,0.997016972094871,1.0,63/232,21.47%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;RNF111;PPP1R11;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;NFX1;NEDD4L;TRIM56;RNF10;TRIM24;TRIM35;RNF216;ITCH;RNF135;STUB1;RNF144B;DTX4;HUWE1;AREL1;NEURL1B;NEURL3;ZNRF1;PIAS1;RNF152;SMURF1;TRIM62;FANCL;ANAPC11;ZNRF3;CDC42;BIRC2;FBXO44;NEURL4;KCMF1;BIRC3;WWP1;CUL3;PRKN;HERC2;NSMCE2;RNF125
prerank,nucleotidase activity (GO:0008252),0.4734445413365087,0.9985975411153304,0.46983311938382544,0.9956958140027166,1.0,3/15,10.36%,NT5C3B;BPNT1;NT5DC3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5137201238152873,0.9984808774142266,0.5183098591549296,0.9886459650216288,1.0,3/11,14.28%,BAG2;PFN1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),0.5137201238152873,0.9984808774142266,0.5183098591549296,0.9886459650216288,1.0,3/11,14.28%,BAG2;PFN1;BAG1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.38755241824038494,0.9972323862115146,0.5065065065065065,0.9885600589322763,1.0,66/248,19.96%,GNA15;RAB8B;MYO1E;RAB32;GNAQ;DHX9;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;MYH9;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;ABCD1;RAP2B;RAB28;KIF14;MYO19;ATP2B1;GPN1;KIF20B;RAB31;TOR3A;RAB11A;ARHGDIB;RAB1B;GBP3;ATL1;DNA2;ABCA4;SAR1A;RRAS2;MMUT;TOR1A;RAB33B;KIF2A;LRRK2;TSR1;GNAI3;RAP1A;ABCA3;GNB5;IRGM;ARL8B;RAB27B;HSP90AA1;CDC42;RHOA;ABCD2;MTG2;GNAI2;ATL2;RHOD;RAB29;DNM1L;MFN1;ATL3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.47150935170116637,0.9961647813574348,0.5006369426751592,0.9878351749950453,1.0,2/16,5.42%,NEIL2;OARD1
prerank,ubiquitin binding (GO:0043130),0.4026956964321683,0.9961630919539229,0.4932221063607925,0.9842201945361286,1.0,21/73,21.05%,OTULINL;NUP62;RNF19B;CXCR4;TNFAIP3;DDI2;SMAD3;IKBKG;MVB12B;TOP2A;USP16;FAF1;VPS28;UBE2N;UBXN2A;BIRC2;PLAA;RAD23B;HSPB1;NSFL1C;PRKN
prerank,hyaluronic acid binding (GO:0005540),0.5072290088919323,0.993779753761441,0.5014619883040936,0.9875124269400222,1.0,3/10,15.32%,CD44;STAB2;CEMIP
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.37724188560863536,-0.9928732129695902,0.475177304964539,0.8523312490959729,1.0,5/12,22.27%,IRS1;GNAS;SHC1;SOCS2;IGF2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5094257383042092,0.9921323834988403,0.5166204986149584,0.9885011778780234,1.0,4/12,13.62%,PYCARD;CASP1;APAF1;ATP2A3
prerank,adenyl ribonucleotide binding (GO:0032559),0.38350650101475753,0.9919398737507518,0.528,0.9853821294471922,1.0,75/291,21.29%,MYO1F;BTK;KCNJ11;ABCA1;MAP4K1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;NEK6;ERN1;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;PIM1;LONP1;MAP3K5;WNK1;ABCD1;KIF14;TRIP13;STK17B;MCM6;TAP1;EIF2B2;CARS2;RPS6KA4;PDE4A;NLK;PRKACB;CDK6;TWF2;ATP5F1A;STK3;UBA2;MYH10;DARS2;WNK4;NIM1K;PTPA;ERCC6;IDE;GCK;STK4;TAP2;HSP90AA1;KSR1;RPS6KA5;SIK2;N4BP2;ABCD2;TAOK1;MINK1;TOP1;PYGL;SMC4;TLK2;MAP4K4;APRT;P2RY1;ABCA2;MARK1;TARS1;GALK1;HCN1;BRSK1;CNBD2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.32536903399059963,-0.9918946754334405,0.4251497005988024,0.8448309103675311,1.0,7/23,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.2996205531984548,-0.990517690242109,0.47904191616766467,0.8383739282515038,1.0,7/27,18.50%,SLC26A2;SLC26A7;SLC25A14;SLC39A8;SLC22A6;SLC25A11;SLC39A14
prerank,sodium channel activity (GO:0005272),0.41354382658132244,0.9842848937173745,0.5167037861915368,1.0,1.0,3/37,4.08%,SCN4B;HCN4;PKD2
prerank,single-stranded RNA binding (GO:0003727),0.41559487453047383,0.9836882156943845,0.5165562913907285,1.0,1.0,19/43,25.89%,DHX9;TLR7;TLR8;LONP1;ENDOV;AGO4;EIF4H;SRA1;AGO3;AGO2;CNBP;HNRNPF;PTBP1;DDX60;ILF3;ZFR;DDX11;AGO1;JMJD6
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4795973816587979,0.9830091973424784,0.5082191780821917,0.9990513163344669,1.0,6/13,20.81%,PRKAR2B;SOX9;GSK3A;CSK;GSK3B;PRKAR1A
prerank,rRNA binding (GO:0019843),0.410799789434524,0.9825809098627851,0.5275938189845475,0.996580742547685,1.0,9/42,16.32%,RPL23;EMG1;CIRBP;GTF3A;ERAL1;RPS14;RRS1;RCC1L;RPL11
prerank,growth factor receptor binding (GO:0070851),0.3912041746412179,0.9811015751600564,0.5459183673469388,0.9970988741782677,1.0,14/95,15.26%,ITGB3;PTPRJ;GRB2;ERN1;IL6R;PYCARD;CD300LF;VEGFB;TIMM50;SDCBP;FYN;ERAP1;SNX2;SRC
prerank,phosphatidylglycerol binding (GO:1901611),0.4790204077196604,0.9784899319813916,0.5131761442441054,1.0,1.0,1/13,1.46%,PLEKHN1
prerank,palmitoyltransferase activity (GO:0016409),0.43674712446152175,0.97841633856707,0.5196662693682956,0.9972287579613447,1.0,8/28,14.44%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;YKT6;ZDHHC1;ZDHHC24
prerank,endodeoxyribonuclease activity (GO:0004520),0.44587034036768153,0.9752750369257638,0.5127582017010935,1.0,1.0,9/20,25.93%,EXO1;ENDOV;DNA2;ERCC5;ERCC1;DCLRE1C;ERCC4;ZRANB3;MBD4
prerank,MHC class II protein complex binding (GO:0023026),0.4902760330206415,0.9744151677674013,0.5168374816983895,1.0,1.0,1/11,1.34%,CD74
prerank,metal ion binding (GO:0046872),0.37501664021843284,0.9742814587925708,0.614,0.9971127216377615,1.0,69/477,14.23%,MMP12;SHH;SYT17;PCDHB6;LCP1;LPL;SMOC2;TPD52;CABP4;ADAM8;RPE;S100B;MASP1;SDF4;IDS;SLC8A1;HPGDS;NEK6;RAP2A;ERN1;MAN1C1;SNCA;APOE;PKD2;KCNIP2;TTN;MCTP1;RASGRP2;PI4K2A;PGS1;ASPH;ANXA1;RP2;AIF1;S100A2;MAP3K5;AGRN;SYT2;CERK;CETN3;ENDOV;TPT1;RASGRP3;ITSN1;TRIM27;SYT10;PPA2;ITPR2;PDCD6;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;NLK;THBS1;PRKACB;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1;STK3;LRRK2;UBA2;LRP1
prerank,mRNA methyltransferase activity (GO:0008174),-0.3615225156113202,-0.9738226793253344,0.5192307692307693,0.8733676802086672,1.0,5/12,14.53%,NSUN2;METTL14;RNMT;METTL16;CMTR1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.455936022127977,0.9708516905830509,0.5290322580645161,1.0,1.0,1/17,1.52%,BLVRB
prerank,adenylyltransferase activity (GO:0070566),-0.3100246673916309,-0.9697534093396148,0.5027322404371585,0.8737507605877989,1.0,8/21,17.44%,ABL1;PAPOLA;SELENOO;PAPOLG;GPHN;NMNAT1;TUT1;KARS1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.49361926004937684,0.9676973643523753,0.5154061624649859,1.0,1.0,1/11,2.77%,AKR1A1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4913838747632992,0.9664327282009627,0.5249643366619116,1.0,1.0,2/10,4.84%,RPE;RENBP
prerank,chloride channel regulator activity (GO:0017081),0.4712847782057247,0.9651662113052236,0.5137362637362637,1.0,1.0,7/14,23.12%,WNK1;STX8;WNK4;SGK3;VAMP8;SGK1;STX7
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.39072716892648995,0.9631614903485202,0.5609243697478992,1.0,1.0,15/60,17.58%,PPM1H;PPP2CB;MTMR3;RPAP2;TIMM50;PPP2CA;ILKAP;LRRC39;LRRK2;PPP1CC;PHLPP1;PTEN;PPP3CB;PPM1M;PPP4C
prerank,RNA polymerase II complex binding (GO:0000993),0.417136301223837,0.9631159760881389,0.5312145289443814,1.0,1.0,11/32,18.03%,DHX9;ZNF326;UVSSA;SCAF1;PCIF1;RTRAF;ELOF1;ERCC5;GTF2B;AGO2;PCF11
prerank,calcium-dependent phospholipid binding (GO:0005544),0.39356566273285165,0.9623207093853575,0.5326797385620915,1.0,1.0,7/49,10.94%,SYT17;MCTP1;ANXA1;SYT2;SYT10;ANXA4;DYSF
prerank,phospholipase A2 activity (GO:0004623),0.4230740500391489,0.9597526203281984,0.5371702637889688,1.0,1.0,8/26,23.55%,PLA2G7;PRDX6;ABHD3;PLAAT3;PNPLA3;PLA2G5;PLA2G4E;PLA2G6
prerank,transferrin receptor binding (GO:1990459),-0.38894923232429,-0.9591942101450694,0.5239616613418531,0.8913967448231408,1.0,4/10,12.68%,SNX4;RGMA;CHUK;CD81
prerank,titin binding (GO:0031432),-0.35393629578630126,-0.9526482390862874,0.5092936802973977,0.8989778005918997,1.0,7/13,36.46%,ACTN2;CALM3;TRIM63;MYBPC1;CALM2;CAMK2D;ANKRD23
prerank,chloride channel inhibitor activity (GO:0019869),0.494315765015916,0.9525438368712354,0.5596465390279823,1.0,1.0,5/10,23.12%,WNK1;STX8;WNK4;VAMP8;STX7
prerank,neuropeptide receptor activity (GO:0008188),0.41825359676732937,0.951864783964549,0.5283893395133256,1.0,1.0,4/29,11.66%,GALR1;SORCS3;GPR37;TACR1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4358186555540896,0.9517189429820995,0.5441176470588235,1.0,1.0,9/22,19.53%,TNFAIP3;PRPF8;WDR81;TAB2;IKBKG;RNF169;TAB3;OPTN;PARP10
prerank,regulatory RNA binding (GO:0061980),0.4036343508087477,0.9488412117174421,0.5761741122565864,1.0,1.0,12/38,20.92%,DHX9;TLR7;RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;TARBP2;AGO2;ZC3H7A;DICER1
prerank,protease binding (GO:0002020),0.3719870031014634,0.9470692477730306,0.601015228426396,1.0,1.0,26/99,21.05%,ITGB3;RFFL;PSAP;TNF;TTN;TNFAIP3;PYCARD;TIMP1;CFLAR;TP53;CRADD;DERL1;CLTC;CCBE1;TWNK;A2M;PTEN;FURIN;BIN1;TRIP4;FLOT1;ITGB1;RIOK3;GSK3B;DPP4;PRKN
prerank,beta-tubulin binding (GO:0048487),0.4175085135821821,0.9464800398359957,0.5686719636776391,1.0,1.0,11/31,21.43%,UXT;FGF13;ARL8A;GJB6;VAPB;CCT5;EML4;ARL8B;TAOK1;CDK5R1;TTLL7
prerank,single-stranded DNA binding (GO:0003697),0.3790913608752153,0.945741344660287,0.595116988809766,1.0,1.0,23/93,20.60%,MCM5;FAM111A;DHX9;NABP1;HMGB1;SAMHD1;LONP1;MCM2;MCM6;APTX;STN1;MCM9;PCBP1;RAD51B;TWNK;ERCC5;REXO4;TOP1;FUBP3;ERCC1;RAD51D;RAD23B;CDC45
prerank,methylated histone binding (GO:0035064),0.37926767456045896,0.9454961552434167,0.5819502074688797,1.0,1.0,18/62,20.25%,CXXC1;BPTF;NCAPG2;MORC3;TAF1;KDM7A;ATRX;CHD1;RBBP5;TRIM24;TTLL12;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.38553299783843326,0.9451172607291225,0.5800214822771214,1.0,1.0,12/53,16.84%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC66A1;SLC25A18;CTNS;SLC1A4;SLC43A1
prerank,muscle alpha-actinin binding (GO:0051371),0.45604151554028377,0.943981304953728,0.5630026809651475,1.0,1.0,5/15,18.50%,PKD2;TTN;LDB3;PDLIM1;PALLD
prerank,zinc ion binding (GO:0008270),0.36562324646417055,0.9409581642151279,0.679,1.0,1.0,86/293,22.76%,MMP12;SHH;ADAM8;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;SKI;RBSN;TIMP1;SORD;P2RX4;SAMHD1;CDA;TP53;KDM7A;CRIP2;SMAD3;RC3H1;WDFY1;EPRS1;LITAF;ACER3;HDAC4;TRIM8;HPF1;NAALADL1;RASSF1;LIMS1;POLR2L;TRIM24;SEC24D;ZCCHC4;MBD1;TAB2;CHORDC1;ERAP1;ATAD3A;CSRP1;TAB3;USP16;IDE;GTF2B;PITRM1;ARHGEF2;KDM4C;RPS27;SLU7;BIRC2;RXRA;MSRB2;TNFSF10;CHD4;KLF7;TET2;RNPEP;KDM5A;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;TARS1;CDADC1;SIRT5;RNF125;CXXC5;KDM2B;ZFP37;MT3;GRIN2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;MDM4;ADAMTS3;LNPEP;NUDT12
prerank,myosin binding (GO:0017022),0.38284102190629904,0.9387109964203706,0.5853920515574651,1.0,1.0,9/55,9.82%,CORO1A;NCKIPSD;CXCR4;PYCARD;RAB14;ARFGEF1;SPATA6;RAB39B;RAB11A
prerank,GABA-A receptor activity (GO:0004890),-0.32814571527668046,-0.9378365601916224,0.5074626865671642,0.927663184092964,1.0,4/18,10.75%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,GDP binding (GO:0019003),0.37883368077287793,0.9372743575698425,0.5974710221285564,1.0,1.0,14/63,16.44%,RAB8B;RAP2A;RAB14;RAP1B;RAB7A;RAP2B;RAB28;RAB31;RRAS2;ARF6;GNAI3;RAP1A;ARL8B;RAB27B
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.3618113895676851,-0.9357600930984749,0.5520833333333334,0.9231234078949816,1.0,4/12,10.75%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,Wnt-activated receptor activity (GO:0042813),0.44571774048700735,0.9349787345315526,0.5633423180592992,1.0,1.0,4/15,9.80%,FZD10;FZD9;FZD3;LRP5
prerank,voltage-gated cation channel activity (GO:0022843),0.3709818631370442,0.9349519964212855,0.6441717791411042,1.0,1.0,12/97,14.32%,PTK2B;KCNJ11;HCN4;PKD2;KCNMA1;CACNA1A;CACNB4;CACNB2;CACNB1;KCNA5;CACNA1B;KCNA6
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.35159049131716286,-0.9341667717259086,0.5410447761194029,0.9173791307150388,1.0,7/13,17.13%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ADH5;ALDH1L1;ALDH1L2
prerank,hexose transmembrane transporter activity (GO:0015149),0.4757657495582662,0.9341479278229159,0.5641748942172073,1.0,1.0,1/12,4.14%,SLC2A3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.48199322914262044,0.9340914491461787,0.5688350983358548,1.0,1.0,3/10,11.54%,EHHADH;ECHS1;ECI1
prerank,ferrous iron binding (GO:0008198),0.4311221221550825,0.933619261604944,0.5581683168316832,1.0,1.0,6/21,19.40%,SNCA;HAAO;FTL;FTH1;TET2;FTO
prerank,organic cation transmembrane transporter activity (GO:0015101),0.45096138189265134,0.9331803666211698,0.5738125802310655,1.0,1.0,2/16,8.69%,SLC7A8;SLC44A2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.2888867231206487,-0.9321516016512896,0.5567567567567567,0.9123358311175571,1.0,6/23,13.47%,DAZAP1;SSB;U2AF2;FMR1;HNRNPU;RBMS3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4303897027316446,0.9304925544690125,0.5450061652281134,1.0,1.0,3/20,8.80%,CARD11;MPP1;CASK
prerank,GTP binding (GO:0005525),0.3637490954972978,0.9294307827705226,0.6609829488465396,1.0,1.0,36/172,18.96%,TUBB;TUBB1;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;GBP3;ATL1;RRAS2;LRRK2;ARF6;TSR1;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;CDC42;RHOA;MTG2;ATL2;RHOD
prerank,I-SMAD binding (GO:0070411),0.4588471531850354,0.9291233690818469,0.5918918918918918,1.0,1.0,3/13,8.62%,TGFBR1;CTNNB1;SMAD3
prerank,transition metal ion binding (GO:0046914),0.35766721496543574,0.9291149389240686,0.745,1.0,1.0,119/397,23.94%,MMP12;SHH;IL1A;MGAT5;ADAM8;PTPN1;NSD1;S100B;SNCA;TET3;ATP7A;GCH1;SKI;RBSN;ATOX1;TIMP1;GYG1;RNF7;SORD;P2RX4;SAMHD1;B4GALT1;CDA;TP53;PIM1;KDM7A;CRIP2;SMAD3;RC3H1;FTL;WDFY1;EPRS1;LITAF;ACER3;HDAC4;TRIM8;FAM20C;HPF1;NAALADL1;ADPRM;RASSF1;LIMS1;POLR2L;TRIM24;SEC24D;ZCCHC4;MBD1;B4GALT7;TAB2;LACC1;AGMO;CHORDC1;GALNT2;ERAP1;ATAD3A;FTH1;CSRP1;TAB3;LARGE1;MGAT5B;USP16;IDE;GTF2B;PITRM1;ARHGEF2;PPM1M;KDM4C;FDX1;GALNT1;RPS27;LOXL3;SLU7;BIRC2;RXRA;MSRB2;TNFSF10;CHD4;KLF7;TET2;RNPEP;KDM5A;MGAT1;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;NEK4;PRKN;TARS1;CDADC1;SIRT5;RNF125;CXXC5;KDM2B;ZFP37;MT3;XXYLT1;GRIN2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;MDM4;ADAMTS3;LNPEP;NUDT12;GALNT3;HMGCL;EEA1;MYCBP2;SCD;UBA5;TIMM8B;POMGNT1
prerank,DNA polymerase binding (GO:0070182),0.42796190297684356,0.9287146252545283,0.5599472990777339,1.0,1.0,3/18,7.03%,PTGES3;HMGB1;LONP1
prerank,RNA methyltransferase activity (GO:0008173),0.43259560583629264,0.9283851155261018,0.5802310654685494,0.9996557027229521,1.0,4/19,14.08%,FBL;METTL4;METTL3;BCDIN3D
prerank,RNA polymerase binding (GO:0070063),-0.31005982606294835,-0.9267597559861707,0.5194174757281553,0.9161553666359801,1.0,5/18,8.19%,SCAF8;PPIB;ANP32B;PHRF1;CCNT1
prerank,histone methyltransferase binding (GO:1990226),0.4565254860519158,0.9267220372981714,0.5481171548117155,1.0,1.0,6/11,25.40%,PRDM12;CTNNB1;PHF1;LCORL;WIZ;HSP90AB1
prerank,antiporter activity (GO:0015297),0.4181235119403386,0.9235734448014196,0.5930087390761548,1.0,1.0,4/20,15.41%,SLC25A16;TMEM241;SLC25A30;CLCN4
prerank,manganese ion binding (GO:0030145),0.373320101852514,0.9234686033797641,0.6019736842105263,1.0,1.0,20/48,24.63%,MGAT5;GYG1;B4GALT1;PIM1;FAM20C;ADPRM;B4GALT7;GALNT2;LARGE1;MGAT5B;PPM1M;GALNT1;MGAT1;ATP13A2;NEK4;XXYLT1;GALNT3;HMGCL;POMGNT1;ABL2
prerank,endopeptidase regulator activity (GO:0061135),0.38950310934384147,0.9226266462816974,0.5926339285714286,0.9998809101661462,1.0,6/40,15.80%,VSIR;CST7;RENBP;SPINT2;PSME3;A2M
prerank,RNA polymerase core enzyme binding (GO:0043175),0.39604429165065375,0.9220053291692435,0.6022727272727273,0.9981576759834742,1.0,10/33,18.03%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;SPTY2D1;ERCC5;GTF2B;AGO2;PCF11
prerank,histone deacetylase activity (GO:0004407),0.4180540728084241,0.9211403956884935,0.5676359039190898,0.9969948965814831,1.0,5/19,14.10%,HDAC5;HDAC4;HDAC6;HDAC9;HDAC11
prerank,clathrin adaptor activity (GO:0035615),0.43997604461569967,0.9207565822631016,0.5804289544235925,0.994699418536635,1.0,5/15,15.68%,LDLRAP1;AP2S1;STON2;STON1;AP2M1
prerank,anion channel activity (GO:0005253),0.3756302560181661,0.919273031930401,0.6207983193277311,0.994878618534746,1.0,13/61,15.41%,LRRC8D;CLCC1;VDAC3;CLIC1;GABRA5;CLCN7;GLRA2;GABRA4;VDAC2;VDAC1;SLC1A4;LRRC8C;CLCN4
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.414592355115995,0.9187018832002647,0.6046228710462287,0.9930878748361299,1.0,8/24,21.45%,ZDHHC14;ZDHHC7;ZDHHC3;YKT6;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.40084983702437843,0.9185020345533089,0.5967741935483871,0.9904918324430083,1.0,13/31,21.89%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K;UBE2R2;UBE2E1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3756786323197868,0.9173966351498735,0.6379310344827587,0.9898455207760365,1.0,12/55,17.61%,SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;ABCC1;SLC16A1;SLC38A10;SLC16A6;SLC13A3;SLC16A13
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4719391465700467,0.9166226162205772,0.5838323353293413,0.9884090004193655,1.0,6/10,26.87%,B4GALT1;A3GALT2;B4GALT7;B4GALT6;B3GALT2;B4GALT5
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3705916376992521,0.9157007515240688,0.605543710021322,0.987320036376875,1.0,7/53,10.21%,CYBB;CYB5R1;XDH;ACADL;MICAL1;KMO;ILVBL
prerank,transcription coregulator binding (GO:0001221),0.3788540807239639,0.9151599218145154,0.6222943722943723,0.9854596256896526,1.0,19/50,24.31%,RPL23;NEK6;CTNNB1;LMO2;FAM89B;SMAD3;HDAC6;MTF2;PPARD;PHF1;PER1;CTBP2;EED;CTBP1;WIZ;UBE2I;TEAD2;CHD6;CNOT2
prerank,guanyl ribonucleotide binding (GO:0032561),0.35687591703642474,0.9139655354703167,0.7124248496993988,0.9850088036807192,1.0,37/196,17.66%,TUBB;TUBB1;RAB8B;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;CNGB1;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;PDE11A;GBP3;ATL1;RRAS2;LRRK2;ARF6;TSR1;GNAI3;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;CDC42;RHOA
prerank,DNA binding (GO:0003677),0.3501550252401355,0.9137032672949801,0.829,0.98262449505195,1.0,131/694,19.00%,NFE2;IRF5;MMP12;CIITA;MEOX1;IRF4;MCM5;IKZF1;GATA1;PCID2;FAM111A;AIM2;NFE2L2;POU2F2;HES7;NR1H4;MLXIPL;ZEB2;DHX9;TLR8;SP7;BARX2;YAF2;NABP1;FOXD2;DNMT3A;BPTF;FOXO3;CEBPA;DDIT3;LRRFIP1;EXO1;MAFK;BRIP1;HMGB1;XRCC5;TAF1;GTF3C4;TEAD1;FLI1;SAMHD1;USF1;TP53;MEF2A;NKX2-1;NRL;LONP1;YY1;RC3H2;CEBPB;ENDOV;CDC5L;TFAP2B;SMAD3;ARID1A;IRF2;HSF1;PPARGC1A;RPL6;ARID3B;SURF6;ARID4A;RNF4;MCM2;HDAC4;MCM6;APTX;SOX9;NR2C2;DENND4A;STN1;GZF1;MBD1;SNAPC3;MTF2;DNA2;MCM9;PMS1;SMARCB1;MAX;NR4A1;IRF1;SAFB2;INO80;PCBP1;SOX6;CUX1;HUWE1;SOX2;C1D;MBD5;ZDHHC1;MEIS1;SREBF1;RAD51B;POU6F1;SPTY2D1;TWNK;ERCC5;NR2C1;THRAP3;REXO4;ERCC6;NUFIP1;RBPJ;TOP2A;OGG1;HIF1A;SMARCAD1;SNAPC4;APLP2;ZGPAT;PPARD;NPAS2;TIGD2;ZNF35;NFYA;CNBP;RPS27;JUNB;ZNF638;MAFB;PHF1;RXRA;ZIC4;POU2F3;CHD4;TOP1;CUX2;FUBP3;ERCC1
prerank,retinoid binding (GO:0005501),-0.29584251096170877,-0.9125759294939936,0.56353591160221,0.9421905016347977,1.0,4/22,24.85%,NR2F2;ALDH1A2;RBP4;RARA
prerank,solute:proton symporter activity (GO:0015295),-0.31928191130484374,-0.9110057474601068,0.5857142857142857,0.9359275541858029,1.0,2/16,1.67%,SLC2A13;SLC33A1
prerank,cell adhesion mediator activity (GO:0098631),0.40996117634569434,0.9107886095318478,0.5953827460510328,0.9860653238345559,1.0,8/24,20.36%,SIRPA;EMB;NPTN;NINJ1;CD47;PALLD;VSTM2L;CNTN4
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3270488303736854,-0.9101221326909775,0.5627376425855514,0.9286349737969394,1.0,2/14,1.32%,MTM1;MTMR7
prerank,ubiquitin-protein transferase activity (GO:0004842),0.35093771168262444,0.9089119287251034,0.794,0.9868876848134859,1.0,74/346,17.86%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2D3;TRAF2;SEL1L;FBXL22;TNFAIP3;MSL2;VPS18;MGRN1;TRAF3;RNF7;HLTF;RNF111;PPP1R11;TAF1;HECTD1;KLHL21;UBE2S;RNF150;RC3H2;MALT1;VPS11;TRIM27;RNF114;UBE2E3;RC3H1;RING1;RNF4;TRAF5;NFX1;UBE2H;NEDD4L;TRIM56;RNF10;MAEA;TRIM24;RNF40;TRIM35;CDC34;RNF216;ITCH;RNF135;FBXL3;RMND5B;STUB1;UBE2G2;RNF144B;DTX4;HUWE1;AREL1;NEURL1B;NEURL3;UBE2J2;ZNRF1;RNF152;SMURF1;TRIM62;FANCL;ANAPC11;UBE2N;ZNRF3;CDC42;UBE2Z;UBE2K
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3656824154035759,0.9086556614174236,0.6295525494276795,0.9844546404492236,1.0,19/69,23.30%,CERS6;ASPG;SOAT2;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;GTF2B;PLAAT3;DGAT2;MOGAT1;NMT1;NAA15;ZDHHC21;ZDHHC2;CERS4;PLA2G4E
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.37684619911767797,-0.9057688460058047,0.5827814569536424,0.930462854709203,1.0,8/10,54.37%,SLC6A11;SLC6A1;SLC10A3;SLC10A1;SLC6A13;SLC10A6;SLC10A4;SLC10A5
prerank,MAP-kinase scaffold activity (GO:0005078),-0.35573448509809075,-0.9047913725725181,0.5748299319727891,0.9236377146698636,1.0,4/11,9.26%,SH3RF1;AKAP13;SPAG9;MAPK8IP3
prerank,PDZ domain binding (GO:0030165),0.36522593659418745,0.9021408079303785,0.649104320337197,0.9948686647235491,1.0,23/61,24.71%,GNG12;FZD3;DOCK4;TBC1D10A;KIF14;ATP2B1;F11R;MAP2K2;SNTG2;ATP2B3;CADM1;PLEKHA1;GRIA1;PTEN;FZD8;PLEKHA2;KIDINS220;FZD2;PRKN;GNG5;NSF;ATP2B4;ATP2B2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.35408376237685374,-0.90091199716169,0.5714285714285714,0.923905406494239,1.0,6/12,29.26%,PDE7A;PDE8A;PDE2A;PDE8B;PDE4D;PDE4C
prerank,cadherin binding (GO:0045296),0.3453793841509693,0.8996440401742287,0.779,0.9970205237451397,1.0,97/315,20.61%,CBL;SNX5;PTPRJ;TRIM25;PTPN1;KLC2;SNX9;PKP2;ASAP1;ITGA6;RPS2;ATIC;LRRFIP1;MYH9;P2RX4;ANXA1;MACF1;CTNNB1;CAPZB;MAPRE1;YWHAB;SND1;ARGLU1;MICALL1;GAPVD1;CLIC1;WASF2;CLINT1;CAPZA1;TBC1D10A;PLIN3;CCT8;LARP1;ARHGAP1;ABI1;RARS1;RPL6;CDH8;EIF4H;VCL;VAPB;PRDX1;F11R;AHSA1;TBC1D2;SCYL1;CDH9;PFN1;PTPRO;YKT6;CDH12;TLN1;PRDX6;TWF2;NUMB;STX5;CDH23;VASN;FNBP1L;PCBP1;STK24;HCFC1;EXOC3;FASN;ARHGAP18;PTPRT;SNX2;PDLIM1;EPS15;GOLGA3;USP8;ATXN2L;FXYD5;EFHD2;SRC;RTN4;DCHS1;CDH19;ARFIP2;LDHA;GCN1;IQGAP1;GIPC1;PICALM;ADD1;ITGB1;SCRIB;SERBP1;ENO1;LASP1;MB21D2;RPL7A;USO1;RPL15;CDK5R1;RPL29;PKM
prerank,aminopeptidase activity (GO:0004177),-0.2775959292796014,-0.8994239299170433,0.6358024691358025,0.9181953728367761,1.0,9/26,20.55%,LTA4H;MMP14;RNPEPL1;MMP16;NPEPPS;BLMH;KDM8;ENPEP;MMP15
prerank,tropomyosin binding (GO:0005523),0.4213699145932545,0.8990365251181748,0.5989717223650386,0.9951836301466628,1.0,2/16,8.27%,PYCARD;TNNT3
prerank,methylation-dependent protein binding (GO:0140034),0.36198222227174737,0.8970350783874221,0.6409989594172737,0.9962824764935264,1.0,16/57,20.25%,CXXC1;BPTF;NCAPG2;MORC3;KDM7A;ATRX;CHD1;RBBP5;TRIM24;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4540204632477561,0.8949487836209115,0.6193820224719101,0.9975210147412148,1.0,11/11,54.63%,DDAH1;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;DDAH2;ARG2
prerank,BMP binding (GO:0036122),-0.3491639497649175,-0.8933775050666336,0.6019736842105263,0.9239842581138491,1.0,1/11,2.44%,NBL1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3595954858307435,0.8924462345367468,0.6728971962616822,0.9995137073883742,1.0,11/72,12.41%,MYO1G;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;EXOC1;SDCBP;TWF2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.39473689429508607,0.8901982483989778,0.6344586728754366,1.0,1.0,2/29,3.27%,PRKAR2B;PKIB
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4444450602948271,0.8900807373631487,0.616991643454039,0.9985812256040131,1.0,2/12,9.10%,TENT4B;TENT5C
prerank,frizzled binding (GO:0005109),-0.25137461485404944,-0.8892975968681285,0.7076923076923077,0.9247500455671566,1.0,11/34,25.79%,WNT4;RNF43;WNT5A;WNT6;WNT5B;MYOC;FZD1;CCDC88C;WNT16;DVL2;WNT11
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4596639543858744,0.8892807538275443,0.6043478260869565,0.9973002096529205,1.0,3/10,16.27%,LAPTM5;ANKRD13A;IDE
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3626673872198197,-0.8888940747006325,0.6116838487972509,0.9168068958678095,1.0,2/10,10.17%,CLCN6;CLCN2
prerank,glucuronosyltransferase activity (GO:0015020),0.4116005425022272,0.8876310559220237,0.6074168797953964,0.9976377261456592,1.0,5/19,25.22%,CHSY1;LARGE1;CHPF;B3GAT2;EXT2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3607946749848839,0.8873502117438818,0.676923076923077,0.9953399690797743,1.0,14/75,17.91%,EHHADH;AKR1A1;DHRS3;HPGD;SORD;DHRS11;HSD17B11;SPR;SDR42E1;ME3;LDHA;IMPDH2;PHGDH;PGD
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.34652026429599186,-0.8864133401464145,0.5725490196078431,0.9139630358629635,1.0,4/12,13.83%,NUDT5;ENTPD5;SLC25A42;CANT1
prerank,mannosyltransferase activity (GO:0000030),0.40476588620174514,0.8855709277225422,0.6032540675844806,0.9958918711869018,1.0,4/21,9.81%,PIGM;PIGV;ALG2;TMTC4
prerank,calcium-release channel activity (GO:0015278),0.4164627908624724,0.8846520511845276,0.6282722513089005,0.9948809415937077,1.0,3/17,8.83%,RASA3;PKD2;ITPR2
prerank,translation elongation factor activity (GO:0003746),0.4318831775371206,0.8840390400283902,0.60778859527121,0.9933734538847524,1.0,2/14,6.94%,GFM1;GTPBP1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.37992666013333853,0.8833493984068983,0.6405895691609977,0.9918798641781756,1.0,15/34,24.66%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K;UBE2R2;UBE2E1;UBE2I;UBE2F
prerank,O-acyltransferase activity (GO:0008374),0.38323016559693474,0.8823331786572864,0.6421173762945915,0.9909075316577625,1.0,4/30,12.37%,LPCAT1;SOAT2;LPCAT2;PRDX6
prerank,growth factor activity (GO:0008083),0.35391948319283906,0.8813424551231025,0.7058823529411765,0.9898527846150443,1.0,9/74,12.65%,MDK;ANGPTL3;OSM;VEGFB;NTF3;INHBA;ARTN;GRN;NRG1
prerank,voltage-gated potassium channel activity (GO:0005249),0.3545845499115477,0.8796159883617803,0.6979166666666666,0.9905064117823227,1.0,6/80,6.99%,KCNJ11;HCN4;KCNK6;PKD2;KCNIP2;KCNMA1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4023580979185087,0.8785118021495383,0.6288532675709001,0.9897129519838771,1.0,5/20,19.75%,OTULINL;USP7;USP9X;USP21;DESI2
prerank,microtubule binding (GO:0008017),0.3436413214480327,0.8783812126943912,0.7887887887887888,0.9871623188402942,1.0,41/222,16.22%,HOOK3;UXT;NEFH;GAS2L1;FGF13;MAP1LC3B;GAS2L3;CCDC88B;MDM1;TPGS1;CCDC69;MACF1;MAPRE1;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;RAB11A;VAPB;TUBGCP4;TUBGCP6;MAP1B;CCDC181;MID2;HDAC6;CEP57L1;KATNA1;HOOK2;KIF2A;LRRK2;HAUS8;FMN1;CAMSAP2;SVBP;DST;EML4
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.36648490959549934,0.8749554229787345,0.6431014823261118,0.9907256181665777,1.0,12/35,23.22%,MMP12;TAF1;TP53;SNAPC3;SMARCB1;PIH1D1;GTF2B;AGO2;POU2F1;TAF1C;H3-3A;GTF2A1
prerank,histone deacetylase binding (GO:0042826),0.34472972888999737,0.8737006219670468,0.7266187050359713,0.9903163655108476,1.0,22/88,19.48%,CIR1;SPI1;HDAC5;BHLHE41;USF1;MTA3;YWHAB;TP53;MEF2A;TAL1;MEF2C;HDAC4;ZMYND15;PKN1;HDAC6;HDAC9;AKAP8L;TOP2A;HSP90AA1;DACT1;CHD4;RBBP4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.43064460248627784,0.8692957786852495,0.635989010989011,0.9954279091601947,1.0,4/13,19.23%,GABRA5;GLRA2;GABRA4;GABRG1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.2577227225946105,-0.8681999230789791,0.6892655367231638,0.9468016047845567,1.0,14/27,28.90%,MED21;PRIMPOL;MED20;POLR3B;PRIM1;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLR1C;POLR1D;POLRMT
prerank,adrenergic receptor binding (GO:0031690),-0.31044654137984584,-0.8676216934283505,0.639344262295082,0.939213555656461,1.0,6/16,18.40%,ARRDC3;GNAS;RAPGEF2;SAV1;MAGI2;UCHL1
prerank,nuclear import signal receptor activity (GO:0061608),-0.31057401733372925,-0.8655180430808486,0.66796875,0.9350617134740089,1.0,7/15,31.17%,TNPO3;IPO5;RANBP6;HIKESHI;TNPO2;KPNA2;KPNA6
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.39497275555224504,0.8622484894338289,0.6550435865504358,1.0,1.0,6/21,17.68%,AKAP5;ARFGEF1;WASF2;ARFGEF2;AKAP8L;AKAP9
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3433670886748917,0.8613343440641471,0.7298674821610601,1.0,1.0,22/91,21.07%,MYO1G;SH3PXD2B;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;EXOC1;SDCBP;TWF2;SNX14;SNX18;PLEKHA5;PICALM;TULP3;LAPTM4B;FCHO2;ATP13A2;MARK1;KCNJ2
prerank,R-SMAD binding (GO:0070412),0.4024651036147281,0.8589999711368712,0.665359477124183,1.0,1.0,4/18,17.31%,RGCC;SMAD3;SMURF1;LDLRAD4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.42049497453872603,0.8583682957572384,0.6556927297668038,1.0,1.0,5/14,19.97%,ELAC2;RPP38;RPP14;PRORP;TSEN2
prerank,ribonuclease P activity (GO:0004526),0.4333434349513714,0.8570957255409942,0.6453900709219859,1.0,1.0,3/11,14.99%,RPP38;RPP14;PRORP
prerank,nuclease activity (GO:0004518),0.34904396613989935,0.8570064754937496,0.7038216560509554,1.0,1.0,20/52,26.03%,EXO1;SAMHD1;SND1;RNASEL;RNASEH1;DNA2;DDX1;ERCC5;REXO4;OGG1;N4BP2;RNASEH2A;DIS3L2;RNASE6;REXO1;DNASE1L1;XRN2;RNASE12;DFFB;RNASE3
prerank,phospholipid transfer activity (GO:0120014),-0.2722150721752493,-0.8553701848239209,0.6893203883495146,0.9491007163665851,1.0,9/21,24.34%,PITPNM2;PITPNC1;TNFAIP8L3;GLTP;PITPNB;MTTP;PRELID2;PRELID3A;PLTP
prerank,cation transmembrane transporter activity (GO:0008324),0.35413201213448625,0.8547768603165155,0.7049356223175965,1.0,1.0,7/48,11.34%,SLC7A8;SLC38A6;SLC36A1;SLC25A38;SLC36A4;SLC8B1;SLC66A1
prerank,general transcription initiation factor binding (GO:0140296),-0.25384791989402444,-0.8537908554505622,0.6914893617021277,0.9438445367379377,1.0,8/25,16.66%,AR;TBP;DR1;PSMC1;RELA;TAF13;PSMC5;RUVBL1
prerank,tRNA binding (GO:0000049),0.35510558221766303,0.8532771378467078,0.6904761904761905,1.0,1.0,12/43,22.85%,SEPSECS;ELP1;TRMT10A;CTU1;YRDC;DARS2;FARS2;AIMP1;RPUSD4;SARS2;SARS1;ELP5
prerank,channel activity (GO:0015267),0.35803027155017164,0.8503799614550321,0.685456595264938,1.0,1.0,4/41,14.09%,AQP1;AQP11;TMEM120A;TRPV3
prerank,peptidase inhibitor activity (GO:0030414),0.3699420258027414,0.8499587056233199,0.6824480369515011,1.0,1.0,4/33,8.98%,CST7;RENBP;TIMP1;SPINT2
prerank,glucose transmembrane transporter activity (GO:0005355),0.4007235696111598,0.8482284106940262,0.6529032258064517,1.0,1.0,1/17,4.14%,SLC2A3
prerank,deoxyribonuclease activity (GO:0004536),-0.3019033088898422,-0.8477994400824869,0.6806083650190115,0.9474140565511123,1.0,3/14,11.53%,MRE11;MAP1S;APLF
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.43967381303417236,0.8463231291359717,0.6701492537313433,1.0,1.0,1/10,2.21%,SLCO2B1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2533939830969919,-0.8457703938957359,0.7087912087912088,0.9438725151651186,1.0,11/25,27.91%,SNX4;EFEMP1;ATXN2;SHC1;LINGO1;HBEGF;CCDC88A;HIP1;EGF;CNOT9;FER
prerank,RNA binding (GO:0003723),0.32364814827925287,0.8446726839097665,0.992,1.0,1.0,330/1321,21.55%,SEPSECS;LGALS3;APOBEC1;RBM47;RFTN1;PCSK9;PCID2;CORO1A;RPL23;RPL17;RBM38;MYO5A;TRIM25;GRB2;EMG1;PTPN1;DHX9;TLR7;TLR8;RPL10A;GFM1;KCTD12;UTP20;PCDH20;ACIN1;NPM3;SF3B2;SF3B1;MKRN1;FBL;ZNF326;ELP1;BCCIP;RBM39;PPIE;EXOSC1;RPS2;TENT4B;DHX38;RRBP1;EIF5B;LRRFIP1;MYH9;SCAF11;NXF1;LAS1L;IREB2;SAMSN1;ANP32A;THOC2;HLTF;SYNE1;HMGB1;XRCC5;SAMHD1;RPL18A;CHCHD1;BTF3;MACF1;CIRBP;CCAR1;CDK11B;MRPL41;MAPRE1;NUDT4;FASTKD3;ACTN4;SND1;GTPBP1;RPS15A;LONP1;TNRC6A;GSPT1;YY1;YTHDF3;CSTF1;RC3H2;TCF20;TMSB4X;P4HB;CASC3;SNRPD2;TRAP1;EIF4A1;GRSF1;ENDOV;ELAC2;ZC3H12D;NKRF;CDC5L;TPT1;MOV10;ERAL1;LARP4B;RBM15B;LARP1;PRPF38B;EIF1;CMSS1;ADAR;RC3H1;ZCCHC7;KRR1;SMG1;TDRD7;PPARGC1A;PCBP3;PUM2;RPP38;RPL6;AGO4;EPRS1;SURF6;FASTKD1;DDX27;HNRNPL;EIF4H;NFX1;MCRS1;PRDX1;CPEB3;TPR;RBMX2;ACTN1;NAP1L1;TRIM56;SON;DDX39B;RBM27;ZC3H18;RPL26;TRMT1;EIF4G3;SNIP1;LGALS1;RNASEL;RPS20;LUC7L3;DIAPH1;APTX;CLTC;CHERP;FAU;PFN1;RPS16;ACO1;TRMT10A;CTU1;ZNF106;PTBP2;AGO3;SECISBP2;GRN;DDX18;DYNC1H1;RNASEH1;PRPF8;NOP9;METTL3;TRA2B;PIN4;UTP11;TWF2;DNA2;HEATR1;TBL2;RPS14;ADARB1;ATP5F1A;RRS1;PPIL4;FAM50A;RPP14;RPGR;SAFB2;DARS1;PCBP1;POLDIP3;RTRAF;MRPL15;RPL19;ZYX;MSI2;UPF3B;RCC1L;DDX1;MYH10;HUWE1;TSR1;C1D;LRP1;NOC2L;SRP19;FASN;ALKBH5;HNRNPD;PES1;RO60;PPP1CC;PUM3;CSRP1;YRDC;DARS2;RPL9;PRKRA;IGF2BP3;IMP3;CPEB4;ATXN2L;PPIG;MRPS9;RBM42;AKAP8L;NOC3L;FAM120C;METAP2;CCDC47;MTDH;THRAP3;NOL7;HEATR6;REXO4;PDIA3;NUFIP1;TOP2A;SMG7;EWSR1;RPS11;RTN4;RPL11;PUS7;TEP1;LSM8;TUT7;TARBP2;ZC3H12C;CPEB2;FARS2;MEX3D;TASOR;HSP90AA1;RPS23;GCN1;MRPS21;UBE2N;RPS4X;LRRC47;SEC63;MRPS14;CRNKL1;PABPC4;MANF;DDX31;NGDN;RBPMS2;MRPL39;AGO2;CNBP;PCF11;RPS27;RPL4;DDX41;ZNF638;ADD1;FYTTD1;RBM34;GOLGB1;MRPL3;RBMS2;SNRNP35;TOP1;FUBP3;SNRNP200;FCF1;DUSP14;SRSF2;SRSF6;MRPS26;HNRNPF;PNN;ERH;WDR75;ROCK2;SERBP1;ENO1;CLNS1A;EXOSC3;PYM1;PABPN1;SLBP;ARCN1;RPL7A;USO1;UTP3;MRPL10;ZFP36L1;HEXIM1;SART1;RPL15;HSPB1;ZC3H7A;SRSF3;DDX51;RPL29;VIRMA;NCOA5;AIMP1;SRSF10;RRP7A;PKM;NAA15;MRPL54;BAG4;RPL22;TES;DICER1;SRFBP1;STRAP;YARS1;TOE1;R3HDM2;IMP4;RPS7;PTBP1;HNRNPA0;RIMS1;LSM14A;LIN28B;DCP1B;EIF2S2
prerank,galactosyltransferase activity (GO:0008378),0.42674204810672156,0.8446713074440144,0.6604850213980028,1.0,1.0,5/11,21.79%,B4GALT1;A3GALT2;B4GALT7;B4GALT2;B4GALT6
prerank,mRNA 5'-UTR binding (GO:0048027),0.3758964458664535,0.844074292599513,0.6694915254237288,0.9984683133018037,1.0,10/24,25.96%,LARP1;RPL26;RPS14;MYH10;CCT5;IGF2BP3;RPS7;RPS13;RPL41;RPL5
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.29472472641476355,-0.843315850989541,0.632,0.9406036466366191,1.0,6/15,17.13%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ALDH1L1;ALDH1L2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3555964157599156,-0.8430950390363694,0.6227106227106227,0.9327909452141351,1.0,6/10,40.37%,INCA1;KAT2B;CDKN1A;CDKN2C;CDKN2D;CDKN2B
prerank,intracellular chloride channel activity (GO:0061778),-0.2993367687739043,-0.8430777911557984,0.672,0.9167191090217521,1.0,9/16,37.72%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.2993367687739043,-0.8430777911557984,0.672,0.9167191090217521,1.0,9/16,37.72%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43264549532614616,0.8426040214933617,0.637155297532656,0.9983228235886875,1.0,3/10,16.27%,LAPTM5;ANKRD13A;IDE
prerank,tau-protein kinase activity (GO:0050321),-0.2818800926173496,-0.841831596353812,0.6858638743455497,0.9114137100600722,1.0,7/20,16.98%,TAOK2;DYRK1A;ROCK1;PHKG2;MARK4;TTBK1;SIK3
prerank,androgen receptor binding (GO:0050681),-0.26916078943249705,-0.838850801153454,0.7112299465240641,0.9095638915177762,1.0,11/25,24.28%,FOXP1;SMARCA4;KDM3A;CALR;SNW1;RNF14;PARK7;TGFB1I1;ARID5A;PRPF6;TRIM68
prerank,nuclear export signal receptor activity (GO:0005049),0.4184489583766054,0.8382438228607046,0.6515373352855052,1.0,1.0,3/11,12.09%,XPO1;CSE1L;XPO6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3998568606271774,0.8376699592066835,0.701058201058201,1.0,1.0,5/15,18.22%,LPCAT1;LPCAT2;ABHD4;PNPLA3;LCLAT1
prerank,peptidoglycan binding (GO:0042834),0.4379428237138122,0.833899989784471,0.6613372093023255,1.0,1.0,2/10,12.42%,TLR2;NOD2
prerank,5'-nucleotidase activity (GO:0008253),0.4098554886070509,0.8324539242809907,0.6850605652759085,1.0,1.0,2/13,10.36%,NT5C3B;NT5DC3
prerank,transcription corepressor binding (GO:0001222),0.36425087352564417,0.8310875423945427,0.6926713947990544,1.0,1.0,11/27,24.31%,NEK6;FAM89B;HDAC6;MTF2;PHF1;PER1;CTBP2;EED;CTBP1;WIZ;CNOT2
prerank,N-acetyltransferase activity (GO:0008080),-0.2736527090562105,-0.8299057294526025,0.7272727272727273,0.9198457724883524,1.0,3/19,9.84%,ESCO1;SAT1;NAT10
prerank,solute:sodium symporter activity (GO:0015370),-0.24544885648275433,-0.828047387197609,0.7345679012345679,0.9158438079123359,1.0,6/27,28.27%,SLC4A10;SLC5A6;SLC5A7;SLC5A3;SLC5A11;SLC20A1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.34637160488889046,0.8267746694605435,0.727076591154261,1.0,1.0,3/48,4.08%,P2RX1;AQP1;PKD2
prerank,adenylate cyclase binding (GO:0008179),0.42476063294584565,0.8249946627970834,0.6850746268656717,1.0,1.0,2/10,8.29%,AKAP5;CAP1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.34459855070313367,0.823980469691696,0.755939524838013,1.0,1.0,10/49,15.61%,PTPRJ;DUSP3;SAMHD1;PLCXD3;DUSP10;FRA10AC1;PTPRO;PXYLP1;PPP1CC;GDPD3
prerank,protein phosphatase 2A binding (GO:0051721),0.37635133442915847,0.8218889589316642,0.7033374536464772,1.0,1.0,8/23,16.13%,TP53;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPA;SMG7
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4143283613658735,0.8205187265231648,0.6749654218533887,1.0,1.0,3/12,12.33%,CDK8;CDK7;CDK6
prerank,neurexin family protein binding (GO:0042043),0.4259619213900888,0.8203854062863454,0.6826783114992722,1.0,1.0,2/10,8.78%,CEL;SYTL4
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.42214380845278054,0.8202622738501931,0.6979472140762464,1.0,1.0,3/10,19.23%,GABRA5;GABRA4;GABRG1
prerank,potassium ion leak channel activity (GO:0022841),0.39957966747249757,0.8193701441611734,0.6890982503364738,1.0,1.0,2/15,7.61%,KCNK6;KCNK13
prerank,voltage-gated anion channel activity (GO:0008308),0.3946957073625046,0.8193353362725394,0.6762402088772846,0.9990289459711508,1.0,4/15,15.41%,VDAC3;VDAC2;VDAC1;CLCN4
prerank,3'-5' exonuclease activity (GO:0008408),-0.22001819986113158,-0.8189303294687353,0.775,0.9264405542670425,1.0,16/45,24.75%,REV3L;PAN2;MRE11;DIS3;ERI1;EXOSC7;APLF;WRN;EXD2;TATDN1;EXOSC9;POLG;PARN;EXD1;EXOSC5;CNOT6L
prerank,neuropeptide binding (GO:0042923),0.37645812111034327,0.8098960608884354,0.7093167701863354,1.0,1.0,3/18,19.83%,GPR37;SORL1;GPR149
prerank,sequence-specific mRNA binding (GO:1990825),0.4215429597063769,0.8093693849831807,0.7104136947218259,1.0,1.0,1/10,2.86%,DHX9
prerank,peptidase activator activity (GO:0016504),0.3608034106267183,0.8092368957066607,0.7,1.0,1.0,2/22,4.38%,VSIR;TANK
prerank,deubiquitinase activity (GO:0101005),0.32003396028420444,0.8079214316626231,0.7909836065573771,1.0,1.0,19/88,16.18%,MINDY4;OTULIN;TANK;TNFAIP3;USP35;OTUD3;ATXN3;STAMBPL1;USP7;USP48;USP31;USP18;MINDY1;USP9X;JOSD2;USP8;USP29;USP21;USP16
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3185822012934968,-0.8062249056233767,0.6724137931034483,0.9426269134599,1.0,4/11,13.91%,HNRNPA2B1;HNRNPA1;NABP2;CTC1
prerank,anion transmembrane transporter activity (GO:0008509),0.40042425038329404,0.8046132308835897,0.6987788331071914,1.0,1.0,1/12,2.21%,SLCO2B1
prerank,NADP binding (GO:0050661),-0.22937722283270612,-0.803149294799606,0.792,0.9404056066183093,1.0,18/32,32.52%,ME1;CRYZL1;HMGCR;GMDS;NOS3;DUS2;MTRR;CBR4;NOS1;NNT;LBR;DHFR;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.39737826567311474,0.8030768626339435,0.703125,1.0,1.0,6/12,24.31%,CNOT8;TOE1;CNOT7;PNLDC1;CNOT1;CNOT2
prerank,metallopeptidase activity (GO:0008237),0.3167708574236942,0.8023036152498582,0.8175403225806451,1.0,1.0,17/113,17.12%,MMP12;COPS6;ADAM8;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19;PRPF8;ERAP1;ECEL1;PSMD7;METAP2;PMPCB;IDE;PITRM1
prerank,Tat protein binding (GO:0030957),0.40145982361385946,0.8022138399803115,0.6949404761904762,1.0,1.0,3/10,12.90%,ACTB;MDFIC;SMARCB1
prerank,microtubule motor activity (GO:0003777),-0.2030012912479859,-0.8016499273314798,0.8571428571428571,0.9352489726855209,1.0,17/51,23.03%,KIF5B;KIF3C;DYNC1I1;SMC3;KIF16B;KIF26B;KIF3B;KIF5A;KIF24;KIF13A;KIF18A;DNAH2;KIF26A;KIF9;KIFC2;KIF1A;KIF7
prerank,calcium:sodium antiporter activity (GO:0005432),0.42321320580267263,0.8014406468426891,0.7190201729106628,1.0,1.0,2/10,10.78%,SLC8A1;SLC8B1
prerank,tubulin binding (GO:0015631),0.31320633780909785,0.8006887496390899,0.928,1.0,1.0,53/295,16.40%,HOOK3;UXT;NEFH;GAS2L1;TBCEL;FGF13;SNCA;MAP1LC3B;GAS2L3;CCDC88B;DIP2B;MDM1;TPGS1;CCDC69;ARL8A;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;RAB11A;VAPB;TUBGCP4;TUBGCP6;SETD2;TPR;MAP1B;CCDC181;MID2;TTLL12;HDAC6;CEP57L1;FYN;RAB11FIP5;KATNA1;AGBL5;INO80;HOOK2;KIF2A;LRRK2;CCT5;HAUS8;AGTPBP1;FMN1;SVBP;DST;EML4;TTLL1;ARL8B
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4128555273230005,0.7996303074545315,0.7049645390070922,1.0,1.0,1/11,5.93%,PPP1R11
prerank,sialyltransferase activity (GO:0008373),0.37141321328181426,0.7980686529410587,0.7113022113022113,1.0,1.0,4/20,10.43%,ST8SIA4;ST6GALNAC4;ST3GAL1;ST8SIA1
prerank,translation initiation factor activity (GO:0003743),0.34066709754376184,0.7977210173885605,0.7466517857142857,0.998432510611572,1.0,14/36,25.17%,EIF3K;EIF5B;EIF4A1;EIF1;EIF2B2;EIF4G3;AGO2;MTIF3;EIF2S2;EIF3E;EIF3C;EIF3M;EIF2S1;EIF2A
prerank,mRNA binding (GO:0003729),0.30857592430511377,0.7949196216336983,0.915,0.9999897469602939,1.0,66/249,21.55%,RBM47;DHX9;SF3B1;PPIE;RPS2;IREB2;THOC2;CIRBP;TP53;YTHDF3;RC3H2;EIF4A1;GRSF1;ZC3H12D;LARP4B;LARP1;RC3H1;TDRD7;PCBP3;PUM2;ANGEL2;HNRNPL;CPEB3;TPR;RPL26;EIF4G3;SNIP1;LUC7L3;RNF40;ACO1;PTBP2;SECISBP2;METTL3;TRA2B;RPS14;ADARB1;PCBP1;UPF3B;MYH10;CCT5;PUM3;IGF2BP3;CPEB4;ZC3H12C;CPEB2;MARF1;PABPC4;RBPMS2;AGO2;CNBP;PCF11;FYTTD1;RBMS2;SNRNP35;FUBP3;SRSF6;SERBP1;SLBP;ZFP36L1;PKM;RPS7;PTBP1;HNRNPA0;LSM14A;DCP1B;EIF2S2
prerank,"DNA binding, bending (GO:0008301)",-0.29622849559267456,-0.7941633512012073,0.751937984496124,0.941404882765289,1.0,2/14,1.42%,FOXC1;FOXD1
prerank,phosphatase activity (GO:0016791),0.3206990138768229,0.7925737855841418,0.8092307692307692,1.0,1.0,10/73,14.59%,LPIN2;PTPRJ;DUSP3;PLPPR1;DUSP10;FRA10AC1;APTX;PTPRO;PXYLP1;PPP1CC
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3424580729268374,0.7893016078328711,0.7584650112866818,1.0,1.0,12/34,20.37%,DBF4;MAP2K2;PARP16;STK3;STRADA;INCENP;ALS2;IRGM;STK4;IQGAP1;TAOK1;CDK5R1
prerank,SUMO binding (GO:0032183),0.3908788402929449,0.7885529621918391,0.7253044654939107,1.0,1.0,5/13,21.17%,RNF111;RNF4;UBA2;SERBP1;HERC2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3974397069544859,0.7875520051523864,0.7525325615050651,1.0,1.0,2/12,7.45%,ITGB3;VEGFB
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3607598043407207,0.7838666575707872,0.7174721189591078,1.0,1.0,6/19,18.48%,ANGPT4;ABI1;NRG1;GAS6;ERCC6;GREM1
prerank,N-acyltransferase activity (GO:0016410),0.33989422567180605,0.782752216192458,0.7728337236533958,1.0,1.0,10/32,24.78%,CERS6;NAA50;PLAAT3;NMT1;NAA80;GNPNAT1;TGM2;CERS4;PLA2G4E;SIRT7
prerank,metalloendopeptidase activity (GO:0004222),0.31570626606936864,0.782047908579426,0.8171487603305785,1.0,1.0,7/76,10.75%,MMP12;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3380709361587819,0.7808858693944978,0.7801578354002254,0.9998524808716962,1.0,9/33,18.03%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;GTF2B;AGO2;PCF11
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3958176482895293,0.7807245900576989,0.6886657101865137,0.9976520592097421,1.0,5/11,21.30%,NAA40;NAA50;NAA15;NAA25;NAA80
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.40378679945665086,0.7791678010692668,0.7336182336182336,0.9972940246583185,1.0,2/10,10.96%,EXO1;MGME1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3053205098803431,-0.7775052990193583,0.7266187050359713,0.9626678458561466,1.0,4/11,17.30%,SAMD8;SGMS2;AASDHPPT;PIGF
prerank,CoA hydrolase activity (GO:0016289),-0.2690645878853045,-0.777170616114056,0.7976190476190477,0.9557859836048412,1.0,4/16,10.70%,HIBCH;ACOT11;ACAA2;ACOT13
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.33642361321646264,0.775010811045694,0.7625570776255708,1.0,1.0,9/32,21.83%,TET3;HSPBAP1;KDM7A;ALKBH5;RIOX2;KDM4C;TET2;FTO;KDM2B
prerank,cAMP response element binding (GO:0035497),0.39473728703368827,0.7723102337681467,0.7418856259659969,1.0,1.0,3/10,12.55%,CREB3L1;CREB3L2;CREB1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3169782504557702,0.7700223108878642,0.7941176470588235,1.0,1.0,14/49,20.31%,TNFAIP3;BABAM2;HDAC6;PRPF8;WDR81;TAB2;IKBKG;RNF169;MINDY1;TAB3;EPS15;OPTN;PARP10;RAD23B
prerank,chloride channel activity (GO:0005254),0.31214762940944685,0.7673537029391351,0.8144654088050315,1.0,1.0,10/59,15.41%,PACC1;CLCC1;CLIC1;GABRA5;CLCN7;GLRA2;TTYH2;GABRA4;SLC1A4;CLCN4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.27248602637979635,-0.7672083404790248,0.766798418972332,0.9646618297276609,1.0,4/16,9.72%,SLC25A12;SLC25A13;SLC25A14;SLC1A5
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3743455819057889,0.7655341315037678,0.728494623655914,1.0,1.0,2/13,11.34%,SLC7A7;SLC66A1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3700743755393267,0.7615493307318927,0.7695417789757413,1.0,1.0,4/13,18.22%,LPCAT1;LPCAT2;PNPLA3;LCLAT1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3743890846437332,0.7613940551360419,0.7566844919786097,1.0,1.0,4/14,23.78%,NME6;AK8;AK5;AK1
prerank,FMN binding (GO:0010181),-0.29671429904446456,-0.7606365682531524,0.7458745874587459,0.967697759989107,1.0,5/11,25.25%,NOS3;DUS2;MTRR;NOS1;NDOR1
prerank,ligand-gated anion channel activity (GO:0099095),-0.2589754654855137,-0.7582144222211267,0.7955555555555556,0.9637027946672616,1.0,4/17,10.75%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.3548900448677419,0.7532748629041692,0.7773584905660378,1.0,1.0,1/18,6.12%,DHRS11
prerank,myosin V binding (GO:0031489),0.36646703170904044,0.7515657070469485,0.7573726541554959,1.0,1.0,4/15,16.44%,RAB14;RAB39B;RAB11A;RAB27B
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.2258962096453598,-0.7498939432612217,0.8589743589743589,0.9689686752886659,1.0,13/27,28.90%,MED21;MED20;POLR3B;TERT;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLR1C;POLR1D;POLRMT
prerank,leak channel activity (GO:0022840),0.35070294992483664,0.7447324720111341,0.7653061224489796,1.0,1.0,2/18,7.61%,KCNK6;KCNK13
prerank,pentosyltransferase activity (GO:0016763),0.3210132429154621,0.7432988369687609,0.7914798206278026,1.0,1.0,11/36,21.28%,ART4;PARP8;PNP;PARP16;TNKS2;LACC1;TIPARP;LARGE1;PARP10;PARP3;SIRT5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3060636746020424,-0.7371078073044408,0.8013245033112583,0.9727179321278784,1.0,5/10,25.67%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3060636746020424,-0.7371078073044408,0.8013245033112583,0.9727179321278784,1.0,5/10,25.67%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,telomeric DNA binding (GO:0042162),0.3170343972852679,0.7349274563278523,0.8293241695303551,1.0,1.0,12/32,24.89%,XRCC5;SMG1;STN1;HNRNPD;SMG7;UPF2;TINF2;TERF2;TELO2;TERF2IP;TEN1;RPA1
prerank,N-methyltransferase activity (GO:0008170),-0.24584237568899803,-0.7324566240315168,0.8659217877094972,0.9716380630086214,1.0,7/20,24.88%,SETD3;METTL5;RNMT;NNMT;PRMT1;TRMT11;N6AMT1
prerank,ribonuclease P RNA binding (GO:0033204),0.3738625365246102,0.7292524695426184,0.7795620437956204,1.0,1.0,2/10,13.19%,RPP38;RPP14
prerank,MAP kinase activity (GO:0004707),0.353468116020924,0.7276812242179029,0.7922971114167813,1.0,1.0,2/14,11.45%,MAPK14;NLK
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.3274740221546545,0.7276185126407432,0.8018867924528302,1.0,1.0,9/25,23.36%,ART4;PARP8;PARP16;TNKS2;TIPARP;PARP10;PARP3;SIRT5;PARP1
prerank,proton transmembrane transporter activity (GO:0015078),-0.19498676596905476,-0.7268030460970994,0.9655172413793104,0.9719063435363492,1.0,10/39,21.46%,SLC33A1;UQCRH;COX5A;NDUFA4;DMAC2L;COX15;UQCRC1;UQCRQ;NNT;COX5B
prerank,tRNA methyltransferase activity (GO:0008175),-0.25235826387714555,-0.7262967807964592,0.8489795918367347,0.9653476872982695,1.0,9/16,34.47%,THUMPD3;TARBP1;TRMT5;LCMT2;TRMT44;TRMT13;TYW3;TRMT12;TRMT9B
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.31520452023846857,0.7229555459299987,0.8145539906103286,1.0,1.0,3/31,6.56%,AQP1;PKD2;TMEM38A
prerank,pre-mRNA binding (GO:0036002),0.3164737777256016,0.7202303348389293,0.8054567022538552,1.0,1.0,9/28,21.25%,HNRNPL;PRPF8;TRA2B;RBM41;TARBP2;SLU7;SRSF6;SLBP;PTBP1
prerank,O-methyltransferase activity (GO:0008171),0.3702688584933519,0.7201854499123344,0.8088888888888889,1.0,1.0,3/10,19.87%,COMT;BCDIN3D;COQ3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3203095734523978,0.7191773538401296,0.8055893074119077,1.0,1.0,1/23,1.53%,SH3PXD2B
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3420627201310272,0.7174246892344587,0.8129032258064516,1.0,1.0,4/15,18.63%,CXXC1;RBBP5;SETD1B;WDR82
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.30486763298995045,0.7163659952747974,0.8530386740331491,1.0,1.0,8/42,20.37%,CCND3;CCND2;CCNL1;CCNE2;CCNYL1;CNPPD1;HEXIM1;CDK5R1
prerank,transcription coactivator binding (GO:0001223),0.33266867397830824,0.7153009301393144,0.815136476426799,1.0,1.0,2/20,8.62%,RPL23;SMAD3
prerank,histone acetyltransferase binding (GO:0035035),0.3282892009797966,0.713988584947232,0.835427135678392,1.0,1.0,5/21,17.17%,TP53;MEF2A;EID1;HIF1A;TRIP4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2744130613819376,-0.7132435108929356,0.8552188552188552,0.9751386073220893,1.0,3/12,16.20%,B3GNT2;B3GALT5;B3GALT1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.2199933982372415,-0.7130798628591571,0.9085714285714286,0.9682533843866882,1.0,10/24,29.07%,PPIP5K2;IP6K1;IP6K2;AK3;ITPKC;PMVK;AK4;CMPK2;NME2;CMPK1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2735016683084303,-0.7114954544022748,0.8571428571428571,0.9632372419685716,1.0,6/13,23.09%,THUMPD3;TARBP1;TRMT10B;TRMT5;WDR4;TRMT11
prerank,pseudouridine synthase activity (GO:0009982),-0.26164480584105154,-0.7098582392802734,0.8287671232876712,0.9583016793857984,1.0,10/13,45.67%,PUS10;TRUB2;PUS1;PUS7L;RPUSD1;TRUB1;PUSL1;RPUSD2;RPUSD3;DKC1
prerank,disordered domain specific binding (GO:0097718),0.31933107429611696,0.7089680509782188,0.8256097560975609,1.0,1.0,9/23,25.67%,TP53;RB1;CLTC;FYN;HSP90AA1;NCOA3;TEAD2;HSP90AB1;DFFB
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3494663904558636,0.7086538091402953,0.8030513176144244,1.0,1.0,5/12,23.22%,TAF1;GTF2B;POU2F1;H3-3A;GTF2A1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.28054332339943416,0.7081799029838096,0.8931140801644398,1.0,1.0,17/83,16.18%,OTULIN;TANK;TNFAIP3;USP35;OTUD3;ATXN3;STAMBPL1;USP7;USP48;USP31;USP18;USP9X;JOSD2;USP8;USP29;USP21;USP16
prerank,FAD binding (GO:0071949),0.3122486698621061,0.7077028974111718,0.8091236494597839,1.0,1.0,3/24,7.90%,CYB5R1;MICAL1;KMO
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3618565932517862,0.7076399892857871,0.8181818181818182,1.0,1.0,4/10,22.77%,ASH1L;SUV39H1;SETD5;SETDB1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.2671219364818747,-0.706475548330469,0.8625954198473282,0.9554024655547498,1.0,8/12,29.94%,SLC25A42;SLC25A23;SLC19A1;SLC25A24;SLC25A5;SLC25A17;SLC35B2;SLC17A9
prerank,ligand-gated calcium channel activity (GO:0099604),0.3233500082309106,0.7054218858046651,0.8116883116883117,1.0,1.0,2/19,5.60%,RASA3;P2RX4
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3149833150675853,0.7052686014262197,0.7980535279805353,1.0,1.0,6/20,19.81%,LPCAT1;LPCAT2;PNPLA3;LCLAT1;DGAT2;MOGAT1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2940950521922723,0.7047654234224203,0.8386041439476554,1.0,1.0,11/40,22.23%,DNMT3A;FBL;METTL4;COMT;PCMTD2;METTL9;SUV39H1;AS3MT;METTL2B;METTL2A;TPMT
prerank,omega peptidase activity (GO:0008242),0.27839766035311103,0.7044778749392999,0.9021406727828746,1.0,1.0,18/89,16.18%,OTULIN;TANK;TNFAIP3;USP35;OTUD3;ATXN3;STAMBPL1;USP7;USP48;USP31;GGH;USP18;USP9X;JOSD2;USP8;USP29;USP21;USP16
prerank,alpha-actinin binding (GO:0051393),0.31753059008345547,0.7040577984357519,0.8107142857142857,1.0,1.0,7/24,18.50%,PKD2;TTN;LDB3;KCNA5;PDLIM1;CACNA1D;PALLD
prerank,myosin II binding (GO:0045159),0.3616814533400808,0.6999328033419544,0.8231797919762258,1.0,1.0,1/10,2.71%,MYL3
prerank,carboxy-lyase activity (GO:0016831),0.31298520342130565,0.6991674746607599,0.8285356695869838,1.0,1.0,6/23,21.59%,DDC;AMD1;PPCDC;ECHDC1;AZIN2;UROD
prerank,filamin binding (GO:0031005),0.3518533736775691,0.6991418189844792,0.7967032967032966,1.0,1.0,4/11,19.92%,MICALL2;RFLNA;FBLIM1;TMEM67
prerank,voltage-gated calcium channel activity (GO:0005245),0.2981442805668632,0.6984726731227976,0.8574635241301908,1.0,1.0,7/37,16.85%,PKD2;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,mRNA 3'-UTR binding (GO:0003730),0.27809816732179105,0.6934956306121651,0.9041237113402062,1.0,1.0,21/79,21.30%,CIRBP;TP53;LARP4B;LARP1;RC3H1;PUM2;ANGEL2;CPEB3;RNF40;SECISBP2;CCT5;IGF2BP3;CPEB4;CPEB2;MEX3D;PABPC4;RBMS2;SERBP1;ZFP36L1;RPS7;HNRNPA0
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3093430463139332,0.692686093105122,0.844047619047619,1.0,1.0,5/26,18.59%,CHSY3;B3GALNT1;CHSY1;B4GALNT1;CHPF
prerank,neuropeptide receptor binding (GO:0071855),0.33854681417043125,0.6925762368259661,0.8279569892473119,1.0,1.0,1/14,8.31%,PPY
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2970244560905565,0.6915366578835155,0.8585858585858586,1.0,1.0,5/34,10.62%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2970244560905565,0.6915366578835155,0.8585858585858586,1.0,1.0,5/34,10.62%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2814766051803677,0.6904168885838942,0.8847385272145144,1.0,1.0,10/55,17.46%,PKD2;ATP2C1;ATP2B1;ITPR2;CACNB2;ATP2B3;ATP2A3;TRPV3;CACNA1D;TMEM165
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2155030985395096,-0.6898576245021326,0.9696969696969697,0.9672053755130898,1.0,7/22,19.35%,CPEB1;ELAVL3;RBMS3;EXOSC8;ZC3H12A;DHX36;EXOSC9
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.3525499743698763,0.6896989144559567,0.8138847858197932,1.0,1.0,4/10,21.83%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,poly(U) RNA binding (GO:0008266),-0.22240280988382022,-0.6896622156617002,0.8826530612244898,0.960625105295156,1.0,4/20,13.47%,DAZAP1;SSB;FMR1;RBMS3
prerank,RNA cap binding (GO:0000339),0.31949984513524937,0.6846137062389036,0.8210526315789474,1.0,1.0,4/16,17.98%,EIF4A1;LARP1;CYFIP1;AGO2
prerank,carboxypeptidase activity (GO:0004180),0.29547616523679354,0.6833293141458918,0.8716517857142857,1.0,1.0,7/35,17.20%,CTSA;CTSZ;NAALADL1;AGBL5;MINDY1;AGTPBP1;PEPD
prerank,actinin binding (GO:0042805),0.3146895950314621,0.6828744990541433,0.8345498783454988,1.0,1.0,6/21,16.85%,PKD2;TTN;NFKB1;KCNA5;CSRP1;CACNA1D
prerank,syntaxin-1 binding (GO:0017075),0.3083207020534524,0.6828315549128963,0.8574969021065675,0.9997202957274328,1.0,5/22,19.78%,VAMP3;STXBP3;LRRK2;STXBP5;UNC13A
prerank,signal sequence binding (GO:0005048),0.29571096457649865,0.6826168213239583,0.8715909090909091,0.997740971458916,1.0,9/35,21.14%,KCNIP2;KDELR2;TIMM22;BABAM2;CEMIP;AP2M1;KPNA1;TOMM20;IPO4
prerank,telomerase RNA binding (GO:0070034),-0.2192119666671049,-0.6820398600581332,0.93048128342246,0.9619764948656657,1.0,9/22,22.92%,SNRPD3;PINX1;HNRNPU;WRAP53;DHX36;TERT;SMG6;PARN;GAR1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.20225745273515447,-0.6812234532008279,0.9315068493150684,0.9561001225275687,1.0,3/28,9.33%,GRIK4;GABRA2;CHRNA7
prerank,exopeptidase activity (GO:0008238),0.2810611787142159,0.678341212887311,0.8844492440604752,0.999765701449353,1.0,14/50,23.42%,CTSA;ZMPSTE24;CTSZ;NAALADL1;GGH;ERAP1;METAP2;PRCP;LAP3;RNPEP;CNDP2;DPP4;LNPEP;DPEP2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3329927148152698,0.6780397144247052,0.8262032085561497,0.9979246301085427,1.0,2/14,13.94%,KCNIP2;KCNA5
prerank,acetyltransferase activity (GO:0016407),-0.19343794507243992,-0.6775825492162062,0.9183673469387755,0.9527763704976695,1.0,4/31,9.84%,ESCO1;ELP3;SAT1;NAT10
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.2810584267368974,-0.674345043689231,0.8675496688741722,0.9492939388308703,1.0,5/10,31.97%,OPLAH;CRMP1;DPYSL2;CAD;DPYSL3
prerank,potassium channel regulator activity (GO:0015459),0.28030856355607964,0.6722398790785314,0.8854625550660793,1.0,1.0,11/49,22.81%,KCNIP2;WNK1;ENSA;NEDD4L;WNK4;SGK3;RASA1;AKAP9;FLNA;CHP1;SGK1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.26598286286603234,-0.672105732531227,0.8639240506329114,0.9448543902858624,1.0,4/11,24.26%,NDUFAF7;PRMT8;PRMT1;PRMT7
prerank,ion channel activity (GO:0005216),0.26907858177944527,0.6682147918708623,0.9159751037344398,1.0,1.0,4/80,6.82%,P2RX1;TMC6;PKD2;CNGB1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.29136336269607976,0.6639399814317063,0.8647342995169082,1.0,1.0,3/25,7.90%,FMO5;MICAL1;KMO
prerank,pyrophosphatase activity (GO:0016462),0.27427228948632787,0.6619975421778775,0.9055793991416309,1.0,1.0,6/50,11.70%,DHX9;NUDT4;PPA2;ATCAY;ADPRM;ENTPD1
prerank,motor activity (GO:0003774),0.2692021533574818,0.6587837426094948,0.907563025210084,1.0,1.0,7/60,10.02%,MYO1E;MYH9;STARD9;KIF14;KIF20B;KIF23;APPBP2
prerank,cGMP binding (GO:0030553),0.3394820096401418,0.6569580350723578,0.8528995756718529,1.0,1.0,2/11,10.65%,CNGB1;PDE11A
prerank,histone acetyltransferase activity (GO:0004402),0.28119412551371414,0.6536154663070375,0.883352208380521,1.0,1.0,6/30,16.25%,SRCAP;TAF1;BAZ1A;NAA40;KAT7;NAA50
prerank,nucleotidyltransferase activity (GO:0016779),0.298105617780212,0.653185321995421,0.8461538461538461,1.0,1.0,4/19,16.51%,TENT4B;PAPSS1;YRDC;TUT7
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.31465649501435694,0.6491462360607736,0.8565459610027855,1.0,1.0,5/14,20.89%,IREB2;ACO1;SDHB;ETFDH;CIAO3
prerank,magnesium ion binding (GO:0000287),0.25507781181249334,0.648907696316656,0.963673057517659,1.0,1.0,37/135,25.63%,HPGDS;NEK6;RAP2A;ERN1;SNCA;PI4K2A;RP2;MAP3K5;CERK;ENDOV;PPA2;PDCD6;NLK;PRKACB;STK3;LRRK2;UBA2;NIM1K;TOP2A;STK4;SIK2;TESC;DIS3L2;MARK1;BRSK1;XXYLT1;NUDT3;ADPRH;NUDT12;HMGCL;IDH1;NT5C3A;ABL2;PSPH;MARK2;NUAK2;DXO
prerank,histone methyltransferase activity (GO:0042054),0.27991811954906315,0.6478870492565549,0.8805620608899297,1.0,1.0,9/32,22.77%,FBL;DOT1L;SETD2;TTLL12;SMYD3;SUV39H1;EED;NSD3;SETDB1
prerank,phosphatase activator activity (GO:0019211),-0.23337841918703747,-0.6474095840347335,0.8918918918918919,0.9597274879017801,1.0,6/14,37.84%,CALM3;GTF2F1;CALM2;FRS2;B3GAT3;PPP1R15A
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.287388633446515,0.6467514513775139,0.8723404255319149,1.0,1.0,2/27,3.48%,RNF180;RNF19B
prerank,organic anion transmembrane transporter activity (GO:0008514),0.25396937994148044,0.6462880226753493,0.9688755020080321,0.9996149742923988,1.0,17/134,15.32%,SLC52A1;SLCO2B1;SLC7A8;SLC38A6;SLC36A1;SLC35B3;SLC25A38;SLC36A4;ABCC1;SLC16A1;SLC66A1;SLC25A18;CTNS;SLCO1B1;SLC35A3;SLC1A4;CD36
prerank,iron ion binding (GO:0005506),0.26561695774231614,0.6441693730428333,0.9093886462882096,0.9994136134582253,1.0,9/48,19.40%,SNCA;HAAO;KDM7A;FTL;AGMO;FTH1;FDX1;TET2;FTO
prerank,store-operated calcium channel activity (GO:0015279),0.3313700600241194,0.6412260527302786,0.8640226628895185,0.9998558792293026,1.0,1/10,4.75%,ORAI2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.260312817716875,-0.6400203651734578,0.9052287581699346,0.9587578223618832,1.0,2/10,9.87%,FAP;DPP8
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3264861276277551,0.6391507242163569,0.8794520547945206,0.999466536827675,1.0,2/11,8.63%,MAP3K5;MAP3K1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2780162965022099,0.6383554187421752,0.8978185993111366,0.9980040968143099,1.0,10/34,22.77%,SETD6;DOT1L;SETD2;TTLL12;ETFBKMT;SMYD3;SUV39H1;EEF1AKMT1;NSD3;SETDB1
prerank,exoribonuclease activity (GO:0004532),0.31493965394359863,0.634950844732182,0.8823529411764706,0.9987180745051039,1.0,4/12,22.25%,EXOSC1;EXOSC3;CNOT7;EXOSC2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.260116819481342,0.6303701824120064,0.9038674033149171,1.0,1.0,9/42,20.36%,SIRPA;EMB;ANXA1;NPTN;PDLIM1;CD47;PALLD;VSTM2L;CNTN4
prerank,snoRNA binding (GO:0030515),0.27303280288288306,0.6269272640359156,0.8927738927738927,1.0,1.0,6/30,15.94%,XRCC5;NUDT4;HEATR1;TSR1;IMP3;NUFIP1
prerank,AMP binding (GO:0016208),0.31234776675225234,0.6221999904458685,0.8813314037626628,1.0,1.0,1/11,3.18%,PFKL
prerank,neuropeptide hormone activity (GO:0005184),0.2829207837613755,0.6201196986355713,0.9007352941176471,1.0,1.0,2/22,14.20%,PPY;NMB
prerank,methyl-CpG binding (GO:0008327),0.27944595402772004,0.6201192500795085,0.9138149556400507,1.0,1.0,7/22,24.63%,TET3;MBD1;LRWD1;ERH;CXXC5;MBD2;ZBTB21
prerank,miRNA binding (GO:0035198),0.26977732752327777,0.6179623053495168,0.9191090269636577,1.0,1.0,12/30,26.72%,RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;AGO2;ZC3H7A;ZC3H7B;AGO1;PUM1;ELAVL1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.30426004646372407,0.6164650053643368,0.9009009009009009,0.9993479196296627,1.0,5/15,24.80%,NDST1;HS3ST4;NDST2;NDST4;HS3ST3A1
prerank,cation channel activity (GO:0005261),0.2411418231761029,0.6138770620104471,0.9623217922606925,0.9992596318208592,1.0,6/94,10.73%,P2RX1;AQP1;PKD2;TMEM38A;TMEM63A;CACNB2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.22076587418263025,-0.612622611304801,0.9259259259259259,0.9712989598524273,1.0,5/15,24.12%,COX5A;NDUFA4;COX15;COX5B;COX8A
prerank,NAD+ binding (GO:0070403),0.30747714510074525,0.6120227538707167,0.8858695652173914,0.9985790804724127,1.0,1/12,4.59%,HPGD
prerank,5'-3' exonuclease activity (GO:0008409),0.2994547390347254,0.6116781703534219,0.9023746701846965,0.996810311649262,1.0,6/14,25.63%,EXO1;TRIR;DCLRE1C;DCP2;XRN2;DXO
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.29689075085843575,0.6114288736552276,0.8951149425287356,0.9949512732147812,1.0,3/12,18.04%,XDH;SDHB;FDX1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.28839509547667186,0.6025298800802348,0.9115384615384615,0.9994628587556669,1.0,1/17,4.05%,NME6
prerank,NAD binding (GO:0051287),0.26945139078804103,0.6011195648565058,0.92046783625731,0.9984715717260397,1.0,3/26,8.93%,HPGD;SORD;QDPR
prerank,amino acid:sodium symporter activity (GO:0005283),0.3073367202546983,0.5981829645857389,0.9073033707865169,0.9985778673621261,1.0,1/11,9.12%,SLC6A15
prerank,SUMO transferase activity (GO:0019789),-0.2087078180201805,-0.5966973052467087,0.9581589958158996,0.9744645030511982,1.0,6/16,27.41%,RANBP2;TOPORS;TRIM28;MDM2;PIAS4;MUL1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3065680211885535,0.5964034880248616,0.9032258064516129,0.9978613898403097,1.0,5/10,26.58%,NAA50;NAA15;NAA25;NAA80;NAA10
prerank,DNA secondary structure binding (GO:0000217),0.26153222925494835,0.5909673193552119,0.9354838709677419,0.9996155585739738,1.0,7/31,19.83%,HMGB1;YY1;MEF2C;RAD51B;ERCC5;RAD51D;LIN54
prerank,acyl-CoA hydrolase activity (GO:0047617),0.27586181264543186,0.5907926517033685,0.9176626826029216,0.9977354398789431,1.0,6/17,24.97%,ABCD1;ACOT9;ACOT2;ACOT8;PLA2G6;ACOT7
prerank,poly(A) binding (GO:0008143),0.2692869957978344,0.5897216562228617,0.9170792079207921,0.9964617600792302,1.0,4/21,18.67%,PPIE;DDX1;PABPC4;RBMS2
prerank,nucleosomal DNA binding (GO:0031492),0.2619163274621952,0.5858412945945007,0.9368811881188119,0.9972044674569317,1.0,9/21,27.80%,ACTB;SMARCB1;CHD4;RBBP4;H3-3A;MBD2;SMARCC1;MTA2;HDAC1
prerank,ATPase activator activity (GO:0001671),0.2672808165358538,0.5810386505025975,0.9214929214929215,0.9983475700193228,1.0,5/20,17.42%,AHSA1;TOR1AIP2;ATP1B3;ATP1B2;DNAJB6
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.18657503500038808,-0.5806944458336664,0.9695431472081218,0.9762907983272271,1.0,11/21,45.48%,KL;FGF9;FGF10;FGF7;FRS2;FGF1;FRS3;FGF18;KLB;FGF22;FGF5
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.24717321663769093,0.5802673904472545,0.9341517857142857,0.9968593135134219,1.0,12/34,24.83%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;CNOT7;EXOSC2;PNLDC1;CNOT1;CNOT2;XRN2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2508982135654796,0.5757018539294881,0.9363425925925926,0.9977593996841654,1.0,2/33,3.48%,RNF180;RNF19B
prerank,NF-kappaB binding (GO:0051059),0.24923777062377217,0.573521250199688,0.9390986601705238,0.9970894102543575,1.0,5/24,20.32%,SETD6;ANXA4;MTDH;FAF1;GSK3B
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.29017605389980544,0.5729540692086125,0.9210526315789473,0.9954635201902131,1.0,4/11,17.86%,UBE4B;STUB1;ANAPC11;UBE2K
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2485775752942878,0.5722269797606274,0.9453924914675768,0.9939517585020201,1.0,11/33,24.83%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;CNOT7;EXOSC2;PNLDC1;DCP2;XRN2
prerank,lysine N-methyltransferase activity (GO:0016278),0.2685295822162271,0.5694140194681352,0.9264705882352942,0.993858628035525,1.0,3/20,13.49%,SETD6;SETD2;ETFBKMT
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.24277903178656912,0.5657969035600524,0.953810623556582,0.9940360077035141,1.0,10/35,25.05%,GATB;ELAC2;ELAC1;BCDIN3D;TARS2;DUS1L;FTO;NT5C3A;DUS3L;GATC
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2719412341072269,0.5581651405034458,0.9361702127659575,0.9963973389899276,1.0,3/12,17.98%,LARP1;CYFIP1;AGO2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2295688440848272,0.5576119683710208,0.9715189873417721,0.9947499397984083,1.0,7/57,12.01%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;CYB5A;CYB561D2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.27961940315248507,0.5547539894118675,0.9282758620689655,0.994380054242298,1.0,1/11,5.64%,SLC35B3
prerank,damaged DNA binding (GO:0003684),-0.14378636783047175,-0.5534762661887984,1.0,0.9815237739458189,1.0,11/44,22.81%,DDB2;DDB1;TDG;XRCC1;XPA;SMC6;SDE2;DCLRE1A;RAD18;POLQ;DCLRE1B
prerank,four-way junction DNA binding (GO:0000400),0.2656260199780394,0.5533658888072884,0.9285714285714286,0.9932423457779432,1.0,4/17,19.70%,HMGB1;YY1;RAD51B;RAD51D
prerank,pyridoxal phosphate binding (GO:0030170),0.25416109060467607,0.550433091453764,0.9392405063291139,0.9928823127300991,1.0,6/20,19.55%,THNSL2;OAT;CBS;ACCS;PSAT1;PYGL
prerank,methyltransferase activity (GO:0008168),0.22558196455473772,0.5447891794593471,0.9617067833698031,0.9938605536953071,1.0,11/46,21.77%,METTL4;MGMT;PRMT3;METTL3;COMT;BCDIN3D;SUV39H1;AS3MT;NSUN4;COQ3;EEF1AKMT1
prerank,TBP-class protein binding (GO:0017025),0.2460380097749154,0.5432709348589448,0.9423076923076923,0.9927067081647335,1.0,7/21,24.87%,TAF1;GTF2B;TAF11;HHEX;YEATS2;GTF2A1;THRA
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2422217380020034,0.5419695302524474,0.9597069597069597,0.9914152093270551,1.0,9/24,28.65%,OSBP;OSBPL8;ARFIP2;PLEKHA5;GOLPH3;PLA2G4E;SESTD1;CERT1;OSBPL5
prerank,microtubule plus-end binding (GO:0051010),0.24857235010417034,0.5364042899928676,0.9525641025641025,0.9920415166692222,1.0,6/20,22.76%,MAPRE1;CLIP2;DST;MAPRE2;FBXW11;CLASP1
prerank,cyclic nucleotide binding (GO:0030551),0.24637097824152057,0.5349322926701642,0.948019801980198,0.9908705846280049,1.0,3/21,11.38%,CNGB1;PDE11A;PDE4A
prerank,calcium channel activity (GO:0005262),0.21019282013104185,0.5317119716616507,0.9836065573770492,0.9903634598642631,1.0,9/84,14.09%,PKD2;ORAI2;P2RX4;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;TRPV3
prerank,poly-purine tract binding (GO:0070717),0.23258659326074285,0.5304292040696382,0.9677033492822966,0.9890899347609498,1.0,5/27,18.67%,PPIE;MCRS1;DDX1;PABPC4;RBMS2
prerank,U6 snRNA binding (GO:0017070),0.25697408788706166,0.5276583061049336,0.9409448818897638,0.988526793907942,1.0,3/14,16.49%,DDX39B;PRPF8;LSM8
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.18735480630376092,-0.5259579599831479,0.9916666666666667,0.984263959390863,1.0,15/15,81.29%,PLA2G12A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G4A;PLA2G3;PLA2G2C;PLA2G2D;PLA2G10;PLA2G1B;PLA2G2E;PLA2G2F;PLA2G4D;PLA2G4E;PLA2G5
prerank,ubiquitin-specific protease binding (GO:1990381),0.23966449928328082,0.5124617559633525,0.9624352331606217,0.9926429197232352,1.0,8/19,28.58%,DERL1;CLTC;PTEN;PRKN;AMFR;SART3;VCP;SUMO1
prerank,snRNA binding (GO:0017069),0.21666533570520924,0.5120249609928758,0.9844444444444445,0.990919342658533,1.0,10/42,21.01%,LSM11;DDX39B;PRPF8;RBM41;LSM8;SNRNP35;SNRPB2;SF3B3;HEXIM1;TOE1
prerank,protein phosphatase activator activity (GO:0072542),0.25147827494782515,0.5044233228141001,0.9562243502051984,0.9916997440979534,1.0,7/13,32.05%,PTPA;PPP2R5C;PPP2R5B;IGFBP3;PHACTR4;PPP2R5A;CALM1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.23458565743846096,0.501531240441999,0.9691119691119691,0.9908708974056749,1.0,5/19,25.57%,GABRA5;GABRA4;GABRG1;GRIK3;GABRG2
prerank,ion gated channel activity (GO:0022839),0.2129875428381532,0.48033808453776267,0.9850931677018634,0.9956020646727656,1.0,3/24,13.44%,TMEM63A;KCNT1;TTYH2
prerank,gap junction channel activity (GO:0005243),0.2125427515532402,0.46707029153574764,0.9841656516443362,0.9970952935197238,1.0,1/22,7.49%,GJB6
prerank,wide pore channel activity (GO:0022829),0.20867302636158894,0.46213487937771375,0.9818840579710145,0.9963713669644124,1.0,1/23,7.49%,GJB6
prerank,sulfotransferase activity (GO:0008146),0.19204357410744805,0.44560400105793346,0.9932279909706546,0.9979268497939623,1.0,3/33,12.78%,SULT4A1;TPST1;CHST15
prerank,active ion transmembrane transporter activity (GO:0022853),0.18366227963225076,0.4336429866857025,0.9966703662597114,0.9980573443789303,1.0,6/37,21.47%,SLCO2B1;CYB5A;SLCO1B1;COX6B1;COX4I1;SLC16A7
prerank,transaminase activity (GO:0008483),0.2182378241025214,0.4319084362325531,0.9872881355932204,0.9964379801932655,1.0,3/11,23.35%,OAT;PSAT1;BCAT1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.21953699830618695,0.4252482823642768,0.9915254237288136,0.9955404293931656,1.0,1/11,6.72%,NUDT4
prerank,lipid phosphatase activity (GO:0042577),0.1913793176691036,0.3960330430274194,0.9960369881109643,0.9968353648856039,1.0,3/14,22.41%,PLPPR1;INPP5K;PLPP7
